<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Microbiol</journal-id><journal-id journal-id-type="publisher-id">ijmicro</journal-id><journal-title-group><journal-title>International Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1687-918X</issn><issn pub-type="epub">1687-9198</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7474384</article-id><article-id pub-id-type="pmid">32908530</article-id><article-id pub-id-type="doi">10.1155/2020/8832728</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Molecular and Immunological Diagnostic Techniques of Medical Viruses</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3235-5992</contrib-id><name><surname>Reta</surname><given-names>Daniel Hussien</given-names></name><email>gebrieldan@yahoo.com</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tessema</surname><given-names>Tesfaye Sisay</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ashenef</surname><given-names>Addis Simachew</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Desta</surname><given-names>Adey Feleke</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Labisso</surname><given-names>Wajana Lako</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gizaw</surname><given-names>Solomon Tebeje</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Abay</surname><given-names>Solomon Mequanente</given-names></name><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Melka</surname><given-names>Daniel Seifu</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Reta</surname><given-names>Fisseha Alemu</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I7">
<sup>7</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>School of Veterinary Medicine, Wollo University, Dessie, Ethiopia</aff><aff id="I2">
<sup>2</sup>Institute of Biotechnology, Addis Ababa University, Addis Ababa, Ethiopia</aff><aff id="I3">
<sup>3</sup>Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia</aff><aff id="I4">
<sup>4</sup>Department of Pathology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia</aff><aff id="I5">
<sup>5</sup>Department of Medical Biochemistry, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia</aff><aff id="I6">
<sup>6</sup>Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia</aff><aff id="I7">
<sup>7</sup>Department of Biology, College of Natural and Computational Sciences, Jigjiga University, Jigjiga, Ethiopia</aff><author-notes><fn fn-type="other"><p>Academic Editor: Pierre Roques</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>4</day><month>9</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>8832728</elocation-id><history><date date-type="received"><day>13</day><month>4</month><year>2020</year></date><date date-type="rev-recd"><day>24</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Daniel Hussien Reta et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Viral infections are causing serious problems in human population worldwide. The recent outbreak of coronavirus disease 2019 caused by SARS-CoV-2 is a perfect example how viral infection could pose a great threat to global public health and economic sectors. Therefore, the first step in combating viral pathogens is to get a timely and accurate diagnosis. Early and accurate detection of the viral presence in patient sample is crucial for appropriate treatment, control, and prevention of epidemics. Here, we summarize some of the molecular and immunological diagnostic approaches available for the detection of viral infections of humans. Molecular diagnostic techniques provide rapid viral detection in patient sample. They are also relatively inexpensive and highly sensitive and specific diagnostic methods. Immunological-based techniques have been extensively utilized for the detection and epidemiological studies of human viral infections. They can detect antiviral antibodies or viral antigens in clinical samples. There are several commercially available molecular and immunological diagnostic kits that facilitate the use of these methods in the majority of clinical laboratories worldwide. In developing countries including Ethiopia where most of viral infections are endemic, exposure to improved or new methods is highly limited as these methods are very costly to use and also require technical skills. Since researchers and clinicians in all corners of the globe are working hard, it is hoped that in the near future, they will develop good quality tests that can be accessible in low-income countries.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Viruses are small segments of nucleic acid, deoxyribonucleic acid (DNA), or ribonucleic acid (RNA) within a protein coat or lipoprotein coat (envelope). Viruses require host resources for their replication because they are obligate intracellular parasites. Once viruses enter the host cells, they take over or hijack the cells' biosynthetic machineries for the replication of their genomes and other components [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>].</p><p>Viral infections are the most common cause of human diseases. Millions of people are still dying because of human immunodeficiency virus (HIV) and hepatitis viruses worldwide. The emerging viruses are also causing serious problems in human population. For example, avian influenza A (H5N1) in 1997, the severe acute respiratory syndrome-coronavirus (SARS-CoV) in 2002&#x02013;2003, pandemic swine influenza A (H1N1) virus in 2009, Ebola virus in 2014, Zika virus (ZIKV) in 2015, and pandemic SARS-CoV-2 recently, among others, have caused several outbreaks in different countries [<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>].</p><p>The morbidity and mortality rates of human viral infections are significantly high [<xref rid="B10" ref-type="bibr">10</xref>]. For example, the pandemic swine influenza A (H1N1) infection in 2009 occurred in 214 countries with more than 18,036 deaths [<xref rid="B5" ref-type="bibr">5</xref>]. In 2010 alone, the number of human deaths due to rabies globally was estimated to be 61,000, with 84% of the deaths occurred in rural areas [<xref rid="B11" ref-type="bibr">11</xref>]. In 2013, approximately, 35,000,000 people were infected with HIV worldwide [<xref rid="B10" ref-type="bibr">10</xref>]. The World Health Organization (WHO) reported 1.34 million deaths of viral hepatitis in 2015 [<xref rid="B12" ref-type="bibr">12</xref>]. As on 6<sup>th</sup> January 2015, H5N1 viruses have killed 402 out of 694 laboratory-confirmed human infections in 16 countries [<xref rid="B13" ref-type="bibr">13</xref>], with a mortality rate of around 58%. Recently, the world is challenged by the novel coronavirus disease 2019 (COVID-19). The disease is caused by the novel coronavirus (SARS-CoV-2). The pathogen first emerged in Wuhan city, Hubei province, China, which has now quickly gained worldwide spread [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. On 11<sup>th</sup> March 2020, the WHO declared the COVID-19 outbreak a global pandemic. According to the WHO, 9, 129, 146 confirmed cases of COVID-19 have been reported worldwide, including 473, 797 deaths since 31<sup>st</sup> December 2019 and as of 24<sup>th</sup> June 2020 [<xref rid="B15" ref-type="bibr">15</xref>]. Therefore, good diagnostic techniques are required to detect these viral infections early and accurately. Early and accurate detection of viral diseases plays a significant role in selecting appropriate therapy timely, minimizing therapy costs, minimizing unnecessary loss of human lives, and controlling the disease. It also helps to develop appropriate disease prevention and treatment strategies, like development of antiviral vaccines and new therapeutic agents [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>].</p><p>Traditionally, laboratory diagnoses of medical viruses are carried out by isolating viruses in embryonated chicken eggs, in tissue culture, or in laboratory animals and visual examination of viral particles in sample using electron microscopy among others [<xref rid="B16" ref-type="bibr">16</xref>]. Many conventional diagnostic tools tend to be cumbersome, time-consuming, expensive, and poorly reproducible [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>]. In contrast, molecular techniques have revolutionized diagnostic virology by detecting the presence or absence of viral nucleic acids in a patient's sample [<xref rid="B18" ref-type="bibr">18</xref>]. Immuno-based techniques still play a great role for the detection and serosurveillance of human viral infections despite the fact that many of the traditional methods are replaced by nucleic acid-based techniques [<xref rid="B20" ref-type="bibr">20</xref>]. Immunological methods detect viral infections by identifying antiviral antibodies or viral antigens in clinical samples [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>]. Here, we describe some of the molecular and immunological diagnostic approaches for the detection of medical viruses.</p></sec><sec id="sec2"><title>2. Molecular Diagnostic Techniques of Medical Viruses</title><p>Nucleic acid-based molecular detection techniques have revolutionized diagnostic virology with their faster, highly sensitive, and highly specific diagnosis [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>]. Since these methods detect specific nucleic acid sequences, nucleic acid-based diagnostic tests can be applied for the detection of virtually any virus that affects humans [<xref rid="B1" ref-type="bibr">1</xref>].</p><sec id="sec2.1"><title>2.1. Nucleic Acid-Based Amplification Techniques</title><p>Molecular techniques that involve the amplification of viral genomic material are extremely sensitive and specific, provide rapid diagnosis, and allow the detection of several viruses at same time [<xref rid="B16" ref-type="bibr">16</xref>]. Nucleic acid amplification techniques are very useful for the detection of viruses that are uncultivable or difficult and harmful to culture, slow growing viruses in culture, and viruses that display antigenic variations [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B25" ref-type="bibr">25</xref>]. The nucleic acid amplification tests are very popular in the diagnosis of viral infections caused by several viruses, including hepatitis C virus (HCV), human immunodeficiency virus (HIV), dengue virus, Epstein&#x02013;Barr virus (EBV), influenza viruses, Zika virus (ZIKV), Ebola virus, and coronavirus [<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>]. Several nucleic acid amplification methods are currently available for the laboratory diagnosis of viral infections worldwide, and their advantages and limitations will be summarized in <xref rid="tab1" ref-type="table">Table 1</xref>.</p><sec id="sec2.1.1"><title>2.1.1. Polymerase Chain Reaction (PCR)</title><p>PCR is a typical example of nucleic acid amplification assay. It has revolutionized the field of molecular diagnosis since developed by Mullis and Faloona [<xref rid="B50" ref-type="bibr">50</xref>]. PCR is based on extraction and purification of DNA molecule and exponential amplification of the target sequence, using a thermostable DNA polymerase and two specific oligonucleotide primers. After the PCR reaction, the amplified product can be detected by several techniques, including gel electrophoresis, colorimetric methods, and sequencing [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>]. Since its inception, PCR has been used for the detection of human viral infections with overall clinical sensitivity ranging from 77.8% to 100% and clinical specificity ranging from 89% to 100% [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B53" ref-type="bibr">53</xref>&#x02013;<xref rid="B55" ref-type="bibr">55</xref>]. These reports suggest that PCR can be employed for the detection of medical viruses in a variety of specimen types. Conventional PCR is still in use by some clinical laboratories worldwide, but it is rapidly replaced by more advanced variants of the technique.</p><p>PCR is a highly versatile technique. A number of variants of the conventional PCR have been developed, but the most important variants are reverse transcription-PCR and real-time PCR [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B10" ref-type="bibr">10</xref>]. The first method was devised to amplify ribonucleic acid (RNA) targets [<xref rid="B1" ref-type="bibr">1</xref>]; the second technique was introduced to quantify deoxyribonucleic acid (DNA) in real time throughout the PCR reactions [<xref rid="B56" ref-type="bibr">56</xref>].</p></sec><sec id="sec2.1.2"><title>2.1.2. Reverse Transcription-PCR (RT-PCR)</title><p>RT-PCR was designed to amplify RNA targets. In this technique, reverse transcriptase (RT) is used to convert viral RNA targets into complementary DNA (cDNA), and then the resulting cDNA is amplified by conventional PCR. Since its development, RT-PCR has been used for the diagnosis of human infection by RNA viruses. Conventional RT-PCR demonstrated overall sensitivity ranging from 73% to 100% and specificity ranging from 99% to 100% in the detection of viral infection [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>]. These data indicate that RT-PCR is an excellent technique for the diagnosis of human infection by RNA viruses. Nowadays, however, the method is not used commonly in clinical specimens owing to its high cost and time-consuming process [<xref rid="B14" ref-type="bibr">14</xref>].</p></sec><sec id="sec2.1.3"><title>2.1.3. Real-Time PCR</title><p>In real-time PCR system, viral nucleic acid amplification and detection steps are carried out at the same time. The detection of the amplification product is relied on the amount of fluorescence emission from the specimen. The fluorescence emission from the specimen is monitored by special thermal cycler. The computer, with appropriate software connected to the thermal cycler, records the data and produces an amplification plot at every reaction cycle [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B59" ref-type="bibr">59</xref>]. The detection and quantification of amplification products can be done by using SYBR green, the TaqMan, and molecular beacon chemistries. The SYBR green dye binds to the minor groove of double-stranded DNA (dsDNA) product and upon excitation by appropriate light, it exhibits improved fluorescence, which is directly proportional to the accumulated dsDNA product. The TaqMan probe is a DNA oligonucleotide with a fluorescent dye termed reporter attached to one end (5&#x02032; base) and quencher on the other (3&#x02032; base) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). TaqMan probes are designed to hybridize to an internal region of a PCR product. During the annealing stage of the PCR, both the primer and the TaqMan probe bind to the template strand. When the Taq DNA polymerase extends the primer, the polymerase cleaves the probe by its the 5&#x02032;-3&#x02032; exonuclease activity. Cleavage of the probe leads to the release of the fluorescent dye (<xref ref-type="fig" rid="fig1">Figure 1</xref>), resulting in fluorescence emission. The amount of fluorescence is directly proportional to the PCR product. Molecular beacon is a small DNA molecule with a fluorescent dye at the 5&#x02032; end and a quencher at the 3&#x02032; end. The sequences at the very 3&#x02032; and 5&#x02032; ends are complementary to each other. The internal part of the molecule is designed to be complementary to the target sequence of a PCR product. When molecular beacon is free in solution, it will adopt a hairpin structure. This brings the fluorophore and quencher in close proximity, leading to absorption of emitted light of the florescent dye by the quencher and hence fluorescence is not detected (<xref ref-type="fig" rid="fig2">Figure 2</xref> A). However, when a molecular beacon hybridizes to the target sequence, the fluorophore and quencher are separated, leading to the emission of fluorescence (<xref ref-type="fig" rid="fig2">Figure 2</xref> B). The amount of fluorescence is directly proportional to the PCR product [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B60" ref-type="bibr">60</xref>].</p><p>Owing to high sensitivity and specificity, short turnaround time for results, and ease of performance [<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B61" ref-type="bibr">61</xref>], most laboratories across the globe employ real-time PCR for the detection and quantification of medical DNA and RNA viruses in clinical specimens. For example, Boppana et al. [<xref rid="B39" ref-type="bibr">39</xref>] used real-time PCR for the detection of cytomegalovirus (CMV) in liquid saliva with overall sensitivity of 100% and specificity of 99.9%, compared with standard rapid culture. The method was also employed for the diagnosis of primary of EBV infection with overall sensitivity of 95.7% and specificity of 100%, compared to serologic assays [<xref rid="B62" ref-type="bibr">62</xref>]. Real-time PCR was also served to determine viral load in herpes simplex encephalitis patients [<xref rid="B40" ref-type="bibr">40</xref>]. The determination of viral loads in patient specimens is crucial as it provides prognostic and predictive information. In this study, patients with higher viral loads in their cerebrospinal fluid (CSF) found to require acyclovir therapy for a longer duration and had a poorer clinical outcome than the patients with lower viral loads in their CSF [<xref rid="B40" ref-type="bibr">40</xref>]. The assay can also be used for the multiplex identification of different viruses. Both TaqMan probe and molecular beacon play crucial roles for multiplex identification of different viruses in a single PCR reaction. In multiplexing assays, different probes/beacons are labeled with different fluorescent dyes [<xref rid="B41" ref-type="bibr">41</xref>]. In multiplex assay, sensitivity of 100% and specificity of 99.6% were reported, compared to immunofluorescence assay, for real-time PCR in the detection of human adenovirus B, C, and E in the throat swab samples [<xref rid="B63" ref-type="bibr">63</xref>]. Ramamurthy and his colleagues [<xref rid="B33" ref-type="bibr">33</xref>] compared multiplex real-time PCR with multiplex conventional PCR for the detection of neurotropic viruses (CMV, EBV, herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) Japanese encephalitis virus (JEV), and varicella-zoster virus (VZV)) in CSF. Out of 147 CSF samples collected from patients with neurological disorders, real-time PCR detected viral pathogens in 88 samples while conventional PCR could only detect the viruses in six samples, suggesting that real-time PCR has higher sensitivity than conventional PCR. Qiu et al. [<xref rid="B64" ref-type="bibr">64</xref>] developed a triplex quantitative real-time PCR assay for rapid and differential detection of human adenovirus (hAdV) serotypes 2, 3, and 7 for potential clinical use. The analytical sensitivity (limit of detection; LoD) of this assay was 10<sup>2</sup> DNA copies/reaction for each of serotypes and no cross-reactions with other respiratory pathogens. The authors concluded that the assay is sensitive and specific and has the potential for clinical use in the rapid and differential detection and quantitation of hAdV serotypes 2, 3, and 7 in human specimens.</p><p>By the incorporation of reverse transcription step, real-time PCR can be combined with the conventional reverse transcription PCR (RT-PCR) to form reverse transcription quantitative real-time PCR (RT-qPCR). RT-qPCR has a number of advantages over the conventional RT-PCR technique, including reduction of contamination, possibility of quantifying the amplicons, and quick assay time since there are no post-PCR processing activities [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B51" ref-type="bibr">51</xref>]. As a result, RT-qPCR is widely deployed for the detection and quantification of several RNA viruses in clinical specimens, including ZIKV, Ebola virus, coronavirus, HCV, respiratory syncytial virus (RSV), dengue virus, HIV-1, and influenza A virus [<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B65" ref-type="bibr">65</xref>&#x02013;<xref rid="B69" ref-type="bibr">69</xref>]. Recently, Corman et al. [<xref rid="B32" ref-type="bibr">32</xref>] developed RT-qPCR for the detection of SARS-CoV-2. The assay targeted envelope protein (E) gene and RNA-dependent RNA polymerase (RdRp) gene of SARS-CoV-2. High LoDs of 5.2 copies/reaction for E-gene and 3.8 copies/reaction for RdRp gene were demonstrated and no cross-reaction with other coronaviruses, suggesting the usefulness of the method for sensitive and specific diagnosis of COVID-19. The RT-qPCR assay (Quanty ZEBOV FAST assay) was evaluated for the detection of Ebola virus in clinical samples. CLONIT Srl (Italy) developed the assay during outbreak of Ebola in Sierra Leone, and it had overall sensitivity of 100% and specificity of 98.63%, compared to RealStar&#x000ae; Filovirus Screen RT-qPCR Kit 1.0 (Altona Diagnostics) [<xref rid="B31" ref-type="bibr">31</xref>]. Gueudin et al. [<xref rid="B68" ref-type="bibr">68</xref>] used RT-qPCR for diagnosis and monitoring of HIV-1 group O infection with LoD of 40 copies/ml and specificity of 100%. The method was applied for ZIKV detection in human serum and urine, and it had LoDs of 2.5&#x02009;PFU/ml and 250&#x02009;PFU/ml in urine and serum, respectively [<xref rid="B30" ref-type="bibr">30</xref>]. J&#x000fa;nior et al. [<xref rid="B70" ref-type="bibr">70</xref>] used RT-qPCR for the detection of respiratory viruses in outpatients with acute respiratory infection. They also compared the performance of RT-qPCR with indirect immunofluorescence assay (IFA). Accordingly, RT-qPCR managed to detect viral pathogens in 88 (88/162) nasopharyngeal aspirates, but IFA detected viral pathogens in only 33 (33/162) specimens. The data indicated that the use of RT-qPCR increased the viral detection by 33.9%. Today, several real-time RT-PCR kits are available commercially. For example, real-time-qPCR test developed by Cepheid AB (Sunnyvale, CA, USA) is commercially available for the qualitative detection of Ebola virus in EDTA venous whole blood or buccal swabs. The assay targets viral nucleoprotein and glycoprotein genes of Ebola Zaire virus. The assay has a LoD of 82 RNA copies/reaction with turnaround time of 98&#x02009;minutes. Simplexa&#x02122; Dengue RT-PCR assay developed by Focus Diagnostics (Cypress, CA, USA) is a commercial kit for detection and typing of dengue virus serotypes 1, 2, 3, and 4 in human serum. The assay targets four serotype specific regions, namely, dengue 1 (nonstructural (NS)5 gene ), dengue 2 (NS3 gene), dengue 3 (NS5 gene), and dengue 4 (capsid gene). The LoDs of the assay are 0.16&#x02009;PFU/ml, 2.0&#x02009;PFU/ml, 0.2&#x02009;PFU/ml, and 0.2&#x02009;PFU/ml for dengue 1, dengue 2, dengue 3, and dengue 4, respectively. Real-Star Zika Virus RT-PCR kit 1.0 is available, developed by Altona Diagnostics (Hamburg, Germany), for qualitative detection of ZIKV specific RNA in human serum or urine. The LoD of the assay is 0.61 RNA copies/<italic>&#x003bc;</italic>l. Abbott RealTime HCV quantitative assay developed by Abbott Laboratories (Rungis, France) is commercially available for HCV RNA quantitation in human serum and plasma. The target sequence for the assay is in the highly conserved 5&#x02032;untranslated region (UTR) of the HCV genome. The LoD of the assay is 12&#x02009;IU/ml when testing human plasma or serum. COBAS TaqMan HIV-1 test developed by Roche Diagnostics (Branchburg, USA) is commercially available for the quantitation of HIV-1 in human plasma. The real-time RT-PCR targets two highly conserved regions of the HIV-1 genome, namely, gag and long terminal repeat (LTR). The assay has LoD of 20 HIV-1 RNA copies/ml. Recently, several developers of diagnostic tests have developed real-time RT-PCR kits for COVID-19, and they are now seeking marking and emergency use authorization (EUA) from regulatory agencies. For example, Co-Diagnostics (Salt Lake City, USA) has developed real-time RT-PCR kit (Logix Smart COVID-19 test) for qualitative detection of nucleic acid from the SARS-CoV-2 in lower respiratory samples (e.g., bronchoalveolar lavage, sputum, and tracheal aspirate) and upper respiratory specimens (e.g., oropharyngeal swabs, nasal swabs, and nasopharyngeal swabs). The kit has received EUA from United States Food and Drug Administration (US FDA) and CE-IVD marking approval. The assay targets RdRp gene of SARS-CoV-2. The LoD of the assay is 9.35&#x02009;&#x000d7;&#x02009;10<sup>3</sup> RNA copies/ml with thermocycler run time of 63&#x02013;90 minutes, depending on PCR equipment. US Centers for Disease Control and Prevention (CDC) has developed three real-time RT-PCR assays for the detection of SARS-CoV-2 genetic material in upper and lower respiratory specimens, and this panel has been granted EUA by the US FDA. CDC real-time RT-PCR panel targets 3 candidate regions of nucleocapsid (N) gene of SARS-CoV-2. The LoD of all assays are 5 RNA copies/reaction. The Agency for Science, Technology and Research (A&#x02217;STAR) and Tan Tock Seng Hospital (TTSH) (Singapore) have developed real-time RT-PCR test (Fortitude Kit 2.0) for qualitative detection of SARS-CoV-2 genetic material in oropharyngeal swabs. The kit has received Singapore Health Sciences Authority's (HAS) provisional authorization for clinical use. The US FDA has not yet approved the kit for clinical use. The assay has LoD of 1000 RNA copies/ml in in oropharyngeal swabs. The kit developers have not yet disclosed the target gene for this assay. BGI Group (Beijing, China) has developed real-time fluorescent RT-PCR kit for the qualitative detection of nucleic acid from the SARS-CoV-2 in throat (oropharyngeal) swabs, nasal swabs, nasopharyngeal swabs, and other respiratory specimens. The company has received an EUA form the China's National Medical Product Administration and the US FDA for its test kit. The assay targets open reading frame 1a and b (ORF1ab) genes of SARS-CoV-2. It has LoD of 150 copies/ml in throat samples with turnaround time of 4 hours. RADI COVID-19 Real-Time PCR kit developed by KH Medical (Korea) has CE-IVD marking and is used for qualitative detection of SARS-CoV-2 in human nasal swab or sputum sample. The assay targets two genes, namely, spike protein (S) gene and RdRP gene of SARS-CoV-2. It has LoD of 0.66 copies/<italic>&#x003bc;</italic>l with turnaround time of 80 minutes.</p></sec><sec id="sec2.1.4"><title>2.1.4. Transcription-Based Amplification Methods</title><p>Transcription-based amplification method includes nucleic acid sequence-based amplification (NASBA) and transcription-mediated amplification (TMA). NASBA and TMA are similar to each other. They are isothermal amplification methods. The entire amplification process is carried out at the temperature of 41&#x000b0;C. In both cases, the viral RNA target is first converted into cDNA with RT and then RNA polymerase synthesizes multiple copies of viral RNA product. The only difference between TMA and NASBA in the amplification process is two enzymes (RT and RNA polymerase) are utilized in case of TMA while NASBA utilizes three enzymes (avian myeloblastosis virus reverse transcriptase (AMV-RT), RNase H, and T7 RNA polymerase) [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B51" ref-type="bibr">51</xref>].</p><p>As depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>, in the NASBA process, three enzymes and two primers work together to exponentially amplify a target viral RNA. Primer 1 (P1) carries at its 5&#x02032; end T7 RNA polymerase promotor region and at its 3&#x02032; end, P1 carries sequence that is complementary to a target viral RNA sequence. Primer 2 (P2) carries a sequence complementary to cDNA strand. The amplification reaction begins with the production of cDNA copy of the viral RNA by RT using P1. RNase H degrades the viral RNA from RNA-DNA hybrid molecules. Then, RT synthesizes dsDNA molecules using P2 and the released DNA strand. Finally, T7 RNA polymerase uses dsDNA molecules as templates to transcribe many viral RNA copies. The above cycle is repeated several times, resulting in the accumulation of many viral RNA copies and ds DNA molecules. The amplified product can either be detected by gel electrophoresis at the end of the assay or in real time using molecular beacon [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B71" ref-type="bibr">71</xref>]. Transcription-based amplification methods have several advantages, for example, they do not require a thermal cycler, so developing countries and budget-restricted laboratories can afford to perform the assays, they have rapid kinetics (requires fewer cycles), and they produce a single-stranded RNA product that is suitable for detection by various techniques [<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>]. Transcription-based amplification methods are suitable for the diagnosis of human viral infections caused by RNA viruses. They can amplify viral genomic RNA, messenger RNA, or ribosomal RNA [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B73" ref-type="bibr">73</xref>]. Ayele et al. [<xref rid="B44" ref-type="bibr">44</xref>] developed NASBA assay that uses gag-based molecular beacons to distinguish between HIV-1 subtype C (C and C&#x02032;) circulating in Ethiopia. The assay demonstrated high levels of sensitivity and specificity for both beacons (90.5% sensitivity and 100% specificity for the C beacon and 100% sensitivity and 95.2% specificity for the C&#x02032; beacon) by considering sequencing as gold standard for genotyping. Moore et al. [<xref rid="B74" ref-type="bibr">74</xref>] also used NSABA for the detection of influenza A H5N1 virus in clinical specimens with a LoD of 10 RNA copies/<italic>&#x003bc;</italic>l along with the same sensitivity as RT-PCR and average turnaround time of 4&#x02009;hours. The NASBA assay was also used for the detection of dengue viral RNA with LoD of 1&#x02009;PFU/ml for all of 4 dengue virus serotypes, no cross-reaction with JEV, and turnaround time of 3&#x02009;hours [<xref rid="B27" ref-type="bibr">27</xref>]. Ender et al. [<xref rid="B26" ref-type="bibr">26</xref>] used TMA for screening of blood donations for HIV-1 and HCV RNA. The TMA assay had LoDs of 16.2 IU/ml for HIV-1 and 3.5&#x02009;IU/ml for HCV. A multiplex NASBA assay was used for simultaneous detection of HIV-1 and HCV in plasma samples. The LoD of the assay for both HIV-1 and HCV was determined to be 1000 copies/ml and no cross-reactions with other selected viruses [<xref rid="B45" ref-type="bibr">45</xref>]. Swenson and his colleagues [<xref rid="B75" ref-type="bibr">75</xref>] used real-time TMA for the detection of HSV-1 and HSV-2 in lesion swab specimens with overall sensitivities of 98.2% and 99.4%, respectively, and specificity of 97.8% and 94.5%, respectively, compared to culture. In one study, real-time NASBA assay was more sensitive than the conventional RT-PCR in the detection of norovirus. In this study, RT-PCR detected 10 pg of standard viral RNA, while the real-time NASBA assay could detect 100&#x02009;fg of standard viral RNA [<xref rid="B76" ref-type="bibr">76</xref>]. These data indicate that the assays are sensitive, specific, and cost-effective for the detection of human infection by RNA viruses.</p><p>TMA-based assays for the detection of HCV and HIV-1 are commercially available, developed by Hologic (San Diego, CA, USA). The Aptima HCV RNA qualitative assay is used for the detection of HCV RNA in human plasma or serum. The assay utilizes TMA to amplify conserved regions within the 5&#x02032;-UTR of the HCV genome. The assay has LoD of 7.5 IU/ml with a specificity of 99.6%. NASBA-based kits for detection of HIV-1, CMV, enterovirus, and RSV are also commercially available, developed by bioM&#x000e9;rieux Clinical Diagnostics. The NucliSens Easy Q RSV A and B assay is developed by bioM&#x000e9;rieux (Marcy l'Etoile, France), and it is used for qualitative detection of RSV in respiratory samples of different types. The assay is based on real-time NASBA, and it targets F gene of RSV. Moore et al. [<xref rid="B77" ref-type="bibr">77</xref>] evaluated the performance of the commercial test kit using 508 respiratory specimens that were tested by direct immunofluorescence and culture. The assay was found to be more sensitive than culture and immunofluorescence assay. The sensitivity and specificity of the assay were determined to be 99% and 87%, respectively, compared to immunofluorescence assay with turnaround time of &#x0003c;4&#x02009;hours.</p></sec><sec id="sec2.1.5"><title>2.1.5. Loop-Mediated Isothermal Amplification (LAMP)</title><p>LAMP is another isothermal nucleic acid amplification method that is extensively utilized for sensitive, specific, rapid, and cost-effective detection of both DNA and RNA viruses in human specimens. The method was first developed by Notomi et al. [<xref rid="B78" ref-type="bibr">78</xref>] and rapidly gained popularity in diagnostic virology. The method employs four to six unique primers and DNA polymerase with strand-displacement activity to amplify target DNA [<xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B79" ref-type="bibr">79</xref>]. The addition of RT in LAMP reaction (RT-LAMP) permits the amplification of RNA target [<xref rid="B80" ref-type="bibr">80</xref>]. Primer sets for LAMP initially reported by Notomi et al. [<xref rid="B78" ref-type="bibr">78</xref>] include the forward inner primer (FIP), backward inner primer (BIP), forward outer primer (F3), and backward outer primer (B3). The primers are specifically designed to recognize six precise regions from a targeted nucleic acid sequence. Nagamine et al. [<xref rid="B79" ref-type="bibr">79</xref>] later added two loop primers, namely, forward loop primer (LF) and backward loop primer (LB), to accelerate LAMP assay. Owing to the use of four to six specific primers, LAMP assay has outstanding sensitivity and specificity in the detection of target nucleic acids [<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B81" ref-type="bibr">81</xref>]. A detailed description of the LAMP reaction mechanism is available in reviews by Becherer et al. [<xref rid="B81" ref-type="bibr">81</xref>], Tomita et al. [<xref rid="B82" ref-type="bibr">82</xref>], and Silva et al. [<xref rid="B83" ref-type="bibr">83</xref>], which use illustrations to explain the mechanism. The LAMP reaction is performed in constant temperature between 60&#x02013;65&#x000b0;C, alleviating the need for expensive specialized equipment. The method requires only inexpensive heating block or water bath, making it very useful under poor laboratory settings [<xref rid="B84" ref-type="bibr">84</xref>]. The LAMP reaction takes turnaround time of &#x0003c;1&#x02009;hour and the amplified product can be detected by several methods, including the real-time measurement of the turbidity caused by precipitated magnesium pyrophosphate using a turbidimeter, visual detection of magnesium pyrophosphate precipitation following completion of the reaction, detection of fluorescence under ultraviolet light or natural light by adding an intercalating fluorescent dye to the final reaction mixture, and visualization of the bands with various sizes using agarose gel electrophoresis [<xref rid="B84" ref-type="bibr">84</xref>&#x02013;<xref rid="B87" ref-type="bibr">87</xref>].</p><p>LAMP assay has been successfully utilized to the rapid detection of a number of DNA viruses in human specimens, such as HSV-1 with LoD of 10 copies of HSV-1 DNA/<italic>&#x003bc;</italic>l and no cross-reactions with other selected viruses [<xref rid="B85" ref-type="bibr">85</xref>], hAdV40 and hAdV41 with LoD of between 50 and 100 copies of DNA/reaction, no cross-reactions with other selected viruses, and turnaround time of 60&#x02009;minutes [<xref rid="B88" ref-type="bibr">88</xref>], EBV with sensitivity of 86.4%, specificity of 100%, compared to serological assay, and only 45&#x02009;minutes of amplification of the target sequences [<xref rid="B89" ref-type="bibr">89</xref>], and CMV with LoD of 10 DNA copies/<italic>&#x003bc;</italic>l, no cross-reactivity with other viruses, and turnaround time of 1&#x02009;hour after RNA extraction [<xref rid="B90" ref-type="bibr">90</xref>].</p><p>The utility of LAMP is expanded by merging it with reverse transcription (RT) into RT-LAMP to allow the rapid detection of RNA viruses in clinical specimens. Recently, for instance, Huang et al. [<xref rid="B91" ref-type="bibr">91</xref>] developed a rapid RT-LAMP assay for diagnosis of SARS-CoV-2 with LoD of 80 copies of viral RNA/ml in a sample within a 30&#x02009;minutes reaction. This assay was validated by using 16 clinical samples (8 positives and 8 negatives) that were also tested by RT-qPCR. The testing results of the assay were consistent with RT-qPCR method, suggesting RT-LAMP assay can be used for rapid, simple, cost-effective, and sensitive detection of SARS-CoV-2 in respiratory samples. Similarly, Lu et al. [<xref rid="B92" ref-type="bibr">92</xref>] developed the RT-LAMP method for rapid detection of SARS-CoV-2 with LoD of 30 RNA copies/reaction and turnaround time of 40&#x02009;minutes . Further, Baek et al. [<xref rid="B93" ref-type="bibr">93</xref>] developed a rapid RT-LAMP assay for early detection of SARS-CoV-2. The assay has LoD of 100 RNA copies/reaction, which is close to that of RT-qPCR with a rapid detection span of 30&#x02009;minutes . RT-LAMP assay has also been developed to detect Middle East respiratory syndrome coronavirus (MERS-CoV) with LoD of 3.4 copies of MERS-CoV RNA/reaction along with the same sensitivity as MERS-CoV RT-qPCR, no cross-reaction to other respiratory viruses, and results available in &#x0003c;1&#x02009;hour [<xref rid="B87" ref-type="bibr">87</xref>]. Kurosaki et al. [<xref rid="B94" ref-type="bibr">94</xref>] detected acute Ebola virus infection by RT-LAMP coupled with a portable device. The sensitivity and specificity of the assay was 100% each, compared to RT-qPCR and turnaround time of 35&#x02009;minutes . In one study, RT-LAMP was more sensitive than conventional RT-PCR and NASBA [<xref rid="B95" ref-type="bibr">95</xref>]. The assay has been also developed for rapid detection of dengue virus [<xref rid="B84" ref-type="bibr">84</xref>], influenza A (H1N1) pdm09 virus [<xref rid="B96" ref-type="bibr">96</xref>], H5N1 avian influenza virus [<xref rid="B97" ref-type="bibr">97</xref>], HCV [<xref rid="B98" ref-type="bibr">98</xref>], HIV-1 [<xref rid="B99" ref-type="bibr">99</xref>], RSV [<xref rid="B46" ref-type="bibr">46</xref>], and ZIKV [<xref rid="B100" ref-type="bibr">100</xref>] in clinical samples. RT-LAMP-based commercial test kits are available for the detection of SARS-CoV-2 in respiratory specimens. The assay is developed by Color Genomics (USA), and it uses three SARS-CoV-2 specific primer sets targeting N gene , E gene , and ORF1a region, respectively, and a fourth control primer set targeting human ribonuclease P (RNaseP). It has LoD of 0.75 copies of viral RNA/<italic>&#x003bc;</italic>l with 70&#x02009;minutes reaction. The assay received EUA from the US FDA in respiratory specimens. Abbott Diagnostic Scarborough, Inc. (USA) has also developed RT-LAMP-based test (ID NOW&#x02122; COVID-19 assay) for direct detection of SARS-CoV-2 in nasal, nasopharyngeal, or throat swabs. The kit has received EUA from US FDA. The assay targets RdRp gene of SARS-CoV-2. The LoD of the test is 125 genome equivalents (GE)/ml with positive results in &#x0003c;5&#x02009;minutes and negative results in 13&#x02009;minutes . LAMP primer sets such as the Loopamp primer set for avian flu H5 and H7 and FluA influenza are commercially available from Eiken Chemical Co., Ltd. (Japan).</p></sec></sec><sec id="sec2.2"><title>2.2. DNA Microarrays</title><p>DNA microarray technologies have the capacity to identify medical viruses [<xref rid="B101" ref-type="bibr">101</xref>]. In DNA microarray diagnosis, fluorescently labeled viral nucleic acids in a test sample are used to screen an array of oligonucleotide probes immobilized on a solid surface (e.g., glass slide). The oligonucleotide probes used here are specific for the genome of the target virus. The results of hybridization between immobilized probes and target sequences labeled with fluorescent dyes are detected and quantified by fluorescence-based detection [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B72" ref-type="bibr">72</xref>].</p><p>Extensive literature exists demonstrating the utility of DNA microarray for the detection of medical viruses in human specimens. Chiu et al. [<xref rid="B102" ref-type="bibr">102</xref>] used DNA microarray for high-throughput multiplex detection of viruses in nasopharyngeal aspirate samples originated from children infected with respiratory viruses. The assay demonstrated overall sensitivity of 87% to 90% and specificity of &#x02265;99% in the detection of RSV, influenza A virus, and rhinovirus/enterovirus compared to RT-PCR. In one study, DNA microarray was utilized for simultaneous detection of HSV-1/2, VZV, EBV, CMV, human herpesvirus-6 types A and B (HHV-6 A/B), and adenovirus in clinical samples with LoD of 10&#x02009;GE/reaction for each virus without cross-reactivity [<xref rid="B103" ref-type="bibr">103</xref>]. DNA microarray was also used to identify viral causes of meningitis and encephalitis with overall sensitivity of 93% and specificity of 100%, compared to single-virus PCR [<xref rid="B104" ref-type="bibr">104</xref>]. DNA microarray was also utilized for high-throughput multiplex detection of gastrointestinal viruses [<xref rid="B105" ref-type="bibr">105</xref>], viruses transmitted by small mammals and arthropods [<xref rid="B106" ref-type="bibr">106</xref>], herpesviruses, enteroviruses and flaviviruses [<xref rid="B107" ref-type="bibr">107</xref>], HIV-1, HIV-2, and hepatitis viruses [<xref rid="B108" ref-type="bibr">108</xref>] and dual infection with two dengue virus serotypes [<xref rid="B109" ref-type="bibr">109</xref>] in human specimens. DNA microarray was used to identify and genotype drug-resistant mutations of HIV [<xref rid="B110" ref-type="bibr">110</xref>, <xref rid="B111" ref-type="bibr">111</xref>] to detect and genotype drug-resistant hepatitis B virus (HBV) mutations [<xref rid="B112" ref-type="bibr">112</xref>], to detect and genotype SARS coronavirus [<xref rid="B113" ref-type="bibr">113</xref>], and to detect and determine lineage of influenza B viruses [<xref rid="B114" ref-type="bibr">114</xref>]. During an outbreak of SARS in China in 2002, DNA microarray also served for the discovery of a new member of the coronavirus family [<xref rid="B115" ref-type="bibr">115</xref>].</p><p>DNA microarray technology is a high-throughput tool as it allows multiplex detection of a large number of potential viral pathogens in clinical specimens [<xref rid="B102" ref-type="bibr">102</xref>&#x02013;<xref rid="B105" ref-type="bibr">105</xref>]. The technique does have a number of limitations nevertheless, including being too expensive to be used for routine clinical diagnosis, labor-intensive, and time-consuming (the hybridization process may take hours to days to complete). Nonspecific hybridization between test materials and immobilized probes can affect the sensitivity of the assay. In addition, designing of specific probes requires almost complete information of the genetic makeup the virus of interest. The assay detects only those viral pathogens that have target probes on the array [<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B116" ref-type="bibr">116</xref>, <xref rid="B117" ref-type="bibr">117</xref>].</p></sec><sec id="sec2.3"><title>2.3. Next-Generation Sequencing (NGS)</title><p>NGS finds itself very useful in diagnostic virology as it can directly analyze viral nucleic acid fragments extracted from clinical specimens [<xref rid="B118" ref-type="bibr">118</xref>, <xref rid="B119" ref-type="bibr">119</xref>]. Generally, NGS involves preparation of test sample, sequencing of the target nucleic acid fragments using one of the available NGS platforms, and analysis of the sequence data using suitable bioinformatic tools [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B120" ref-type="bibr">120</xref>]. Several companies produce different NGS machines that use different methods of sequencing, reagents, and data analysis tools [<xref rid="B119" ref-type="bibr">119</xref>]. For example, pyrosequencing (Roche 454) detects release of pyrophosphate following incorporation of nucleotides in a DNA polymerization process. Illumina's NGS platforms detect release of fluorescent labels from incorporated nucleotides in a DNA polymerization process. The emerging technologies like Oxford nanopore (MinIon) platform sequences the target nucleic acid by sensing the ionic current of DNA/RNA molecules that pass through the nanopores [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B120" ref-type="bibr">120</xref>]. Despite its high sequence error rate (up to 38.2%) [<xref rid="B121" ref-type="bibr">121</xref>], MinION nanopore sequencer has merits over other NGS platforms. Firstly, it can generate longer read lengths (up to 882 kb) in real time [<xref rid="B122" ref-type="bibr">122</xref>], making it suitable for whole genome sequencing of viral pathogens with short turnaround time [<xref rid="B123" ref-type="bibr">123</xref>, <xref rid="B124" ref-type="bibr">124</xref>]. Secondly, it is portable and no Internet is required for analysis, making it deployable in the field during outbreaks of viral infections [<xref rid="B125" ref-type="bibr">125</xref>]. Thirdly, it has low capital cost, making it affordable in low-income countries and budget-restricted laboratories across the globe [<xref rid="B121" ref-type="bibr">121</xref>].</p><p>NGS has been used in diagnostic virology for several applications. Recently, Kustin et al. [<xref rid="B126" ref-type="bibr">126</xref>] used NGS for rapid and robust identification of respiratory viruses in clinical samples. It was applied to track influenza A (H1N1) pdm09 virus [<xref rid="B127" ref-type="bibr">127</xref>]. Dessilly et al. [<xref rid="B128" ref-type="bibr">128</xref>] used NGS for the detection of HIV-1 drug resistance mutations. NGS was also conducted to discover a new Ebola virus [<xref rid="B129" ref-type="bibr">129</xref>].</p><p>Unlike PCR and DNA microarray methods, NGS does not require prior knowledge of genomic sequences of the viral pathogens. It does not also require target specific PCR primers and oligonucleotide probes [<xref rid="B126" ref-type="bibr">126</xref>, <xref rid="B130" ref-type="bibr">130</xref>]. However, the use of NGS in clinical laboratories is limited because of the following reasons: the turnaround time, the number of samples per run, cost of sequencers, and requirement of skills in bioinformatics [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B128" ref-type="bibr">128</xref>, <xref rid="B131" ref-type="bibr">131</xref>].</p></sec></sec><sec id="sec3"><title>3. Immunological Diagnostic Techniques of Medical Viruses</title><p>The humoral branch of the immune system makes antibodies in response to viral infections. This natural response of the human body against viral infection is utilized for the development of immunological diagnostic methods. Several immunological diagnostic techniques are available for the detection human viral infections in clinical samples, including enzyme-linked immunosorbent assay, western blotting, immunofluorescence assay, and hemagglutination inhibition assay. The principles of these assays rely on the formation of antigen-antibody complex and consist of clinical specimens, whole virus or viral antigen, and an indicator [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p><sec id="sec3.1"><title>3.1. Enzyme-Linked Immunosorbent Assay (ELISA)</title><p>In ELISA, enzyme conjugated antibody is utilized to detect the presence of specific antiviral antibody or viral antigen in human specimens. In positive sample, the reaction between an enzyme conjugated with an antibody and colorless chromogenic substrate leads to the formation of a colorful product. In the absence of antigen/antibody in the clinical specimen, no color is produced. The intensity of the color is directly proportional to the amount of antigen-antibody complex formed. The color change can be observed by the naked eye or read by a spectrophotometer, which can measure the absorbance. Several enzymes, including alkaline phosphatase, horseradish peroxidase (HRP), and <italic>&#x003b2;</italic>-galactosidase, have been used for ELISA. There are several variants of ELISA, but the two main types are antigen-capture ELISA (also called sandwich ELISA) and antibody-capture ELISA (also called indirect ELISA) [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B132" ref-type="bibr">132</xref>]. As illustrated in <xref ref-type="fig" rid="fig4">Figure 4</xref>, the first method detects viral antigen by immobilizing antibody specific for the viral protein of interest on a microtiter well [<xref rid="B22" ref-type="bibr">22</xref>]; the second technique detects antiviral antibody in a patient sample by coating whole virus or viral protein on a microtiter well [<xref rid="B133" ref-type="bibr">133</xref>].</p><p>ELISA is sensitive and specific, easy to perform, and has a short turnaround time for results. Consequently, the assay has been developed and extensively utilized for the detection and serosurveillance of human viral pathogens. Recently, Adams et al. [<xref rid="B134" ref-type="bibr">134</xref>] developed antibody-capture ELISA for the detection of SARS-CoV-2 IgM or IgG in human plasma samples. The assay was tested by using 40 plasma samples from RT-PCR-confirmed SARS-CoV-2 infected patients and 50 plasma samples from healthy control. It demonstrated overall sensitivity of 85%, compared to RT-PCR and specificity of 100% in the detection of anti-SARS-CoV-2 IgG or IgM in plasma samples. This assay detected IgG levels in all of RT-PCR positive individuals from &#x02265;10 days following symptoms onset with a sensitivity of 100%. Similarly, Colavita et al. [<xref rid="B135" ref-type="bibr">135</xref>] developed antibody-capture ELISA for the detection of anti-SARS-CoV-2 IgG, IgM, and IgA in serum samples. The assay was validated using 553 serum samples collected from suspected and confirmed SARS-CoV-2 infection cases, healthy donors, and patients positive for other infections or autoimmune conditions. The assay showed overall sensitivity of 91.7% and 97.9% for the detection of IgG and IgA in serum sample, respectively, and specificity of &#x0003e;96% for all antibody types, compared to IFA reference test. Chen et al. [<xref rid="B22" ref-type="bibr">22</xref>] also developed antigen-capture ELISA for the detection of MERS-CoV in clinical specimens. The assay demonstrated a LoD of &#x0003c;1&#x02009;ng of MERS-CoV-recombinant nucleocapsid protein/ml and specificity of 100%. Antigen-capture ELISA was developed for rapid detection of dengue virus NS1 and differentiation of DENV serotypes in human specimens. The overall sensitivity and specificity of the test were 84.85% and 100%, respectively, compared to RT-qPCR, and the sensitivity rates for serotyping were 88.2%, 94.7%, 75%, and 66.6% for DENV serotype 1 (DENV1), DENV2, DENV3, and DENV4, respectively, with no cross-reactivity among serotypes [<xref rid="B136" ref-type="bibr">136</xref>]. ELISA was also employed for the detection of several other medical viruses, including Ebola virus [<xref rid="B133" ref-type="bibr">133</xref>], HSV-2 [<xref rid="B137" ref-type="bibr">137</xref>], SARS-CoV [<xref rid="B138" ref-type="bibr">138</xref>], hepatitis viruses [<xref rid="B139" ref-type="bibr">139</xref>], H5N1 influenza virus [<xref rid="B140" ref-type="bibr">140</xref>], and ZIKV [<xref rid="B141" ref-type="bibr">141</xref>].</p><p>Commercial antibody-capture ELISA-based test kit (Anti-ZIKV IgA, IgG or IgM ELISA) is available, developed by Euroimmun AG (Germany), for serodiagnosis of acute and past ZIKV infections. The assay uses ZIKV-specific NS1 recombinant antigen. The overall sensitivity and specificity of the assay are 100% and 94%, respectively, compared to RT-PCR. Creative Diagnostics (USA) also developed sandwich ELISA-based commercial kit (HIV 1 and 2 Ag/Ab ELISA kit) for qualitative determination of antigens or antibodies to HIV-1 and HIV-2 in human serum or plasma samples. The assay uses recombinant HIV antigens (HIV-1 glycoprotein (gp)41, gp120, and HIV-2 gp36) and anti-HIV viral gag protein p24 antibodies. The LoD of the assay for the detection of HIV p24 antigen is about 1pg/ml. Moreover, Bio-Rad (France) developed NS1 Ag capture ELISA-based commercial kit (Platelia Dengue NS1 Ag) for the qualitative or semiquantitative detection of dengue virus NS1 antigen in human serum or plasma samples. The assay employs anti-NS1 monoclonal antibody (Mab) as capture antibody and anti-NS1 Mab-HRP conjugate as detection antibody. The sensitivity rates of the assay related to virus serotype are 88.9%, 87.1%, 100%, and 93.3% for DENV1, DENV2, DENV3, and DENV4, respectively, compared to RT-PCR, and specificity of the assay is 100% for all serotypes. Recently, Euroimmun AG (Germany) has developed antibody-capture ELISA-based kit (Anti-SARS-Cov-2 ELISA IgG) for qualitative detection of IgG to SARS-CoV-2 in human serum or plasma samples. The assay uses recombinant S1 protein of SARS-CoV-2 as capture antigen. The assay has received EUA from US FDA for use in authorized laboratories. The estimated sensitivity and specificity of the assay are 90% and 100%, respectively, compared to nucleic acid amplification test. Epitope Diagnostics, Inc. (USA) has also developed two types of ELISA kits (COVID-19 IgG ELISA and COVID-19 IgM ELISA Kits) for the detection of anti-SARS-CoV-2 IgG and IgM in human serum samples, respectively. COVID-19 IgG ELISA kit uses SARS-CoV-2 recombinant antigen and HRP labeled anti-human IgG antibody. COVID-19 IgM ELISA employs anti-human IgM antibody and HRP labeled SARS-CoV-2 recombinant antigen. The assays have a LoD of 5IU/ml. The kits are approved by FDA for clinical and research use.</p></sec><sec id="sec3.2"><title>3.2. Western Blotting Analysis</title><p>Western blotting (also known as immunoblotting) assay detects viral proteins or antiviral antibodies. For detection of viral proteins, denatured whole viral proteins are first separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Viral proteins are then electrotransferred onto nitrocellulose membrane. The membrane is then incubated with enzyme conjugated antibodies specific for the viral proteins. If the viral proteins are bound by enzyme labeled antibody, addition of a chromogenic substrate leads to the formation of colored bands at the sites of the viral antigens (<xref ref-type="fig" rid="fig5">Figure 5</xref>) [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B132" ref-type="bibr">132</xref>]. For detection of antiviral antibodies, viral specific denatured proteins are electrophoretically blotted onto nitrocellulose membrane after subjected to SDS-PAGE. The membrane is then incubated with patient serum. If the patient serum contains antibodies against the viral proteins, they will bind to their specific viral proteins. The addition of enzyme conjugated secondary anti-human antibody and a chromogenic substrate results in the production of colored bands at the locations of the viral proteins [<xref rid="B142" ref-type="bibr">142</xref>].</p><p>Immunoblotting has been used in clinical diagnosis for serosurveillance and as confirmatory tests for human viral infection. He et al. [<xref rid="B143" ref-type="bibr">143</xref>] developed western blot assay for detection of antibodies against SARS-CoV in human serum samples. The assay demonstrated a sensitivity of 98.3% and specificity of 90.9%, compared to IFA. Western blotting assay was also used for the detection of anti-Chikungunya virus antibody in human serum. Sensitivity of 83.3% and specificity of 96.7% were demonstrated by the assay using 30 sera from confirmed Chikungunya virus infected patient and 30 normal sera [<xref rid="B144" ref-type="bibr">144</xref>]. In one study, western blotting was a promising method for surveillance of HIV-1 infection in resource-limited regions [<xref rid="B145" ref-type="bibr">145</xref>]. The assay was also used for the detection and confirmation of HCV and HIV infections [<xref rid="B146" ref-type="bibr">146</xref>&#x02013;<xref rid="B148" ref-type="bibr">148</xref>]. Western blotting assay is also commercially available. For example, J. Mitra and Co. Pvt. Ltd (Mumbai, India) developed commercial kit (HIV 1 and HIV 2 western blot) for the detection of antibodies to HIV-1 and HIV-2 in human serum or plasma samples. The assay uses preblotted nitrocellulose membrane strips with resolved HIV-1 viral lysate and HIV-2 antigen (gp36). The assay has 100% sensitivity and 100% specificity when compared with licensed western blot test. GS HIV-1 Western Blot kit for the detection of antibodies to HIV-1 in human serum, plasma, or dried blood spots is also available developed by Bio-Rad Laboratories (Redmond, USA). The assay uses preblotted nitrocellulose membrane strips with resolved HIV-1 viral proteins. The assay has 100% sensitivity and 87.2% specificity, compared to licensed HIV-1 western blot test.</p></sec><sec id="sec3.3"><title>3.3. Immunofluorescence Assay</title><p>Immunofluorescence assay is commonly conducted for the detection of viral antigens or antiviral antibodies in clinical samples. The assay is conducted in two formats: direct immunofluorescence assay (DFA) that detects viral antigens in patient sample [<xref rid="B149" ref-type="bibr">149</xref>] and indirect immunofluorescence assay (IFA) that detects antiviral antibody [<xref rid="B150" ref-type="bibr">150</xref>] or viral antigen [<xref rid="B151" ref-type="bibr">151</xref>] in clinical specimen. In the DFA, antibody that recognizes viral antigen is directly conjugated to fluorescent dye. In the IFA, viral antigen specific antibody is unlabeled and is detected with a second fluorescently labeled anti-human antibody (<xref ref-type="fig" rid="fig6">Figure 6</xref>). IFA is more sensitive than DFA because several fluorescently labeled anti-immunoglobulin antibodies bind to each antiviral antibody, increasing the intensity of fluorescence at the site of each antiviral antibody. The most widely used fluorescent dye in diagnostic virology is fluorescein isothiocyanate (FITC), which emits an intense yellow-green fluorescence, but rhodamine, which emits a deep red fluorescence, is also available. After staining, the specimen is examined under fluorescence microscope with a source of incident UV light [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B132" ref-type="bibr">132</xref>].</p><p>IFA was used for the diagnosis of SARS. The assay showed 100% sensitivity and 100% specificity in the detection of anti-SARS-CoV IgG in human serum samples when compared to RT-PCR [<xref rid="B150" ref-type="bibr">150</xref>]. Madhusudana et al. [<xref rid="B152" ref-type="bibr">152</xref>] developed IFA for the detection of anti-rabies virus antibodies in human serum and CSF. When compared to the mouse neutralization test, the assay demonstrated a sensitivity of 97.2% and a specificity of 97.9%. IFA was also used for direct detection of HSV antigen in clinical specimens with sensitivity of 84.6% and specificity of 95.7%, compared to the tissue culture method [<xref rid="B151" ref-type="bibr">151</xref>]. Moreover, IFA was applied for subtyping of influenza A virus with 100% agreement to RT-PCR [<xref rid="B153" ref-type="bibr">153</xref>]. IFA was also used for the detection of EBV [<xref rid="B21" ref-type="bibr">21</xref>] and as a confirmatory test for HIV-1 [<xref rid="B154" ref-type="bibr">154</xref>]. Concerning DFA, in one study, it showed 60% sensitivity and 96% specificity in the detection of pandemic influenza A (H1N1) pdm09 in children when compared to RT-qPCR [<xref rid="B149" ref-type="bibr">149</xref>]. In another study, DFA showed high specificity (99&#x02013;100%) in comparison to RT-qPCR for the detection of RSV in children [<xref rid="B155" ref-type="bibr">155</xref>]. IFA-based commercial test kit (Anti- ZIKV IIFT) is available, developed by Euroimmun AG (Germany), for the detection of ZIKV infection. The assay uses the complete ZIKV particles as antigen. Consequently, cross-reactivities with antibodies against viruses of the flavivirus family can occur. De Ory et al. [<xref rid="B156" ref-type="bibr">156</xref>] evaluated the performance of the assay using 126 positive and 102 negative samples. The assay showed 96.8% sensitivity and 72.5% specificity. OXOID Limited (UK) developed DFA-based kit (IMAGEN influenza virus A and B test) for the detection and differentiation of influenza A virus and influenza B virus in human specimens. The assay uses FITC labeled anti-influenza A virus or influenza B virus monoclonal antibodies. The assay has 100% sensitivity and 100% specificity, compared to the cell culture method.</p></sec><sec id="sec3.4"><title>3.4. Hemagglutination Inhibition (HI) Assay</title><p>Some viruses such as dengue virus, adenovirus, rubella virus, measles virus, and influenza virus have hemagglutinin antigen on their surfaces that binds and agglutinates RBCs termed hemagglutination (HA). The inhibition of the ability of the viruses to agglutinate RBCs is utilized for the development of HI assay. In the HI assay, serial dilutions of serum sample are prepared in a microtiter plate. Then, a specified amount of viral hemagglutinin is added. Finally, appropriate RBCs are added. The absence of HA indicates a positive reaction. This is judged by tilting the microtiter plate, which allows free RBCs to stream (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The dilution rate where complete inhibition of agglutination of RBCs occurred is recorded. The HI titer, therefore, is the reciprocal of the last serum dilution which completely inhibits HA [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B132" ref-type="bibr">132</xref>, <xref rid="B157" ref-type="bibr">157</xref>]. HI was utilized for a number of applications in diagnostic virology. The assay was used for serosurveillance of influenza A (H1N1) pdm09 virus [<xref rid="B158" ref-type="bibr">158</xref>] and measles virus [<xref rid="B159" ref-type="bibr">159</xref>]. In one study, HI assay was applied to assess the efficacy of pandemic influenza vaccine [<xref rid="B160" ref-type="bibr">160</xref>]. In a validation study using sera from 79 RT-qPCR-confirmed cases and 176 sera from a nonexposed population, HI assay showed high sensitivity (92%) and specificity (91%) for the detection of human infection with 2009 pandemic H1N1 virus [<xref rid="B161" ref-type="bibr">161</xref>].</p><p>Immunological diagnostic methods are widely employed in routine clinical diagnosis of human viral infections worldwide. The methods have several advantages, such as high sensitivity and specificity, relatively simple to conduct, rapidity, and possibility of testing several specimens simultaneously [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B138" ref-type="bibr">138</xref>]. However, immunological-based assays do have several limitations. The assays are subject to interferences. Interferences in immunoassays may result from the presence of (a) cross-reactive agents in the sample that carry similar or the same epitopes as the viral antigen of interest, leading to false-positive result [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B162" ref-type="bibr">162</xref>]; (b) endogenous antibodies, like autoantibodies, heterophilic antibodies, or human anti-animal antibodies in the specimen. Despite the fact that viral antigen is not present in the sample, endogenous antibodies may interact with antiviral antibodies or detection antibodies, leading to false-positive result [<xref rid="B162" ref-type="bibr">162</xref>, <xref rid="B163" ref-type="bibr">163</xref>]. The specificity of immunoassay may be affected when they are used in malaria-endemic areas. As it is known, <italic>Plasmodium</italic> induces nonspecific polyclonal B-cell activation that leads to generation of nonspecific antibodies [<xref rid="B164" ref-type="bibr">164</xref>]. These broad specific antibodies may react with a variety of antigens, leading to false-positive test. In one study, of 34 samples from PCR confirmed malaria patients, 14 samples were positive or borderline for anti-ZIKV antibodies in commercially available ZIKV ELISA test kit. When these 14 samples were tested using virus neutralization assay, ZIKV infection was not demonstrated in the 11 samples [<xref rid="B165" ref-type="bibr">165</xref>]. HI assay is laborious and time-consuming. The interpretation of the assay results between laboratories may be different as no standard reagents are available for the assay [<xref rid="B153" ref-type="bibr">153</xref>, <xref rid="B157" ref-type="bibr">157</xref>, <xref rid="B166" ref-type="bibr">166</xref>]. In case of IF assay, prolonged exposure of specimen to UV light leads to fading of fluorescence that could result in false-negative test [<xref rid="B167" ref-type="bibr">167</xref>]. Reagents and equipment that are used in some of the immunoassays are expensive [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>].</p></sec></sec><sec id="sec4"><title>4. Status of Diagnostic Methods of Medical Viruses in Ethiopia</title><p>Most of viral diseases are endemic to Ethiopia [<xref rid="B168" ref-type="bibr">168</xref>]. Serosurveys have demonstrated the high prevalence rate of HBV [<xref rid="B169" ref-type="bibr">169</xref>, <xref rid="B170" ref-type="bibr">170</xref>], HCV [<xref rid="B170" ref-type="bibr">170</xref>], HIV [<xref rid="B171" ref-type="bibr">171</xref>], and HSV-2 [<xref rid="B137" ref-type="bibr">137</xref>]. The population is vulnerable to rabies [<xref rid="B172" ref-type="bibr">172</xref>] and influenza [<xref rid="B173" ref-type="bibr">173</xref>]. Rotaviral diarrhea is the leading cause of morbidity and mortality in children [<xref rid="B174" ref-type="bibr">174</xref>]. Recently, like other nations in the globe, public health and economic sectors of Ethiopia are heavily challenged by COVID-19 pandemic.</p><p>Immunological methods, mostly commercial ELISA test kits [<xref rid="B137" ref-type="bibr">137</xref>, <xref rid="B169" ref-type="bibr">169</xref>] and immunochromatographic test kits [<xref rid="B170" ref-type="bibr">170</xref>, <xref rid="B175" ref-type="bibr">175</xref>], are used for the detection of viral infections in most clinical laboratories in the country. IFA technology is available only in Ethiopian Public Health Institute for the detection of rabies virus infection in suspected dogs that bit humans [<xref rid="B176" ref-type="bibr">176</xref>]. Conventional RT-PCR is used for the detection of influenza virus in human specimens in National Influenza Laboratory [<xref rid="B173" ref-type="bibr">173</xref>]. Recently, the RT-qPCR technique is widely used in several research institutes, universities, and clinical laboratories for the detection of SARS-CoV-2 in clinical samples. In general, few molecular techniques such as conventional PCR and RT-PCR are utilized in research institutes and universities for research purposes. Since most laboratories are budget-restricted and do not have trained laboratory personnel, molecular methods are not used for routine clinical diagnosis of human viral infections in the country. Nationwide use of RT-qPCR technologies for the diagnosis of COVID-19 and the experiences obtained will open the door to introduce molecular techniques for routine laboratory testing of other human viral infections.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>The introduction of nucleic acid-based diagnostic tests into diagnostic virology has made tremendous improvement in the detection of human viral infections. Since nucleic acid-based diagnostic tests are highly sensitive and specific, they play a crucial role in the diagnosis and control of medical viruses. Molecular diagnostic methods diagnose viral infections by detecting viral RNA or DNA. Therefore, these techniques can pick infected individuals before antibody response is mounted against the virus in question. This is especially important in young, elderly, and immunosuppressed patients. However, they are beyond the reach of resource-limited nations due to their high cost, instrumentation complexity, and requirement for technical expertise. Immunoassays also play a significant role in the diagnosis and serosurveillance of viral infections worldwide. Although immunotechniques are easy to perform and inexpensive compared to molecular methods, they are not widely available in low-income countries. Consequently, scientists are working hard to develop inexpensive good quality tests in low-income nations. Moreover, most countries in the developing world are training their citizens abroad and inland at postgraduate level by opening relevant departments and institutes.</p></sec></body><back><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobo</surname><given-names>F.</given-names></name><name><surname>Talavera</surname><given-names>P.</given-names></name><name><surname>Concha</surname><given-names>&#x000c1;.</given-names></name></person-group><article-title>Diagnostic approaches for viruses and prions in stem cell banks</article-title><source><italic toggle="yes">Virology</italic></source><year>2006</year><volume>347</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2005.11.026</pub-id><pub-id pub-id-type="other">2-s2.0-33645019720</pub-id><pub-id pub-id-type="pmid">16380145</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>J. A.</given-names></name><name><surname>Punt</surname><given-names>J.</given-names></name><name><surname>Stranford</surname><given-names>S. A.</given-names></name><name><surname>Jones</surname><given-names>P. P.</given-names></name></person-group><source><italic toggle="yes">Kuby Immunology, S</italic></source><year>2013</year><publisher-loc>New York, NY, USA, 7th edition</publisher-loc><publisher-name>W.H. Freeman and Company</publisher-name><fpage>p. 555</fpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>D. L.</given-names></name><name><surname>Perdue</surname><given-names>M. L.</given-names></name><name><surname>Cox</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>1998</year><volume>72</volume><issue>8</issue><fpage>6678</fpage><lpage>6688</lpage><pub-id pub-id-type="doi">10.1128/jvi.72.8.6678-6688.1998</pub-id><pub-id pub-id-type="pmid">9658115</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsitch</surname><given-names>M.</given-names></name><name><surname>Cohen</surname><given-names>T.</given-names></name><name><surname>Cooper</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Transmission dynamics and control of severe acute respiratory syndrome</article-title><source><italic toggle="yes">Science</italic></source><year>2003</year><volume>300</volume><issue>5627</issue><fpage>1966</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1126/science.1086616</pub-id><pub-id pub-id-type="other">2-s2.0-12444346408</pub-id><pub-id pub-id-type="pmid">12766207</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><collab>World Health Organization (WHO)</collab><source><italic toggle="yes">Pandemic (H1N1) 2009-update 100. Weekly Update</italic></source><year>2010</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/2010_05_14/en/index.html">http://www.who.int/csr/don/2010_05_14/en/index.html</ext-link></comment></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasil</surname><given-names>P.</given-names></name><name><surname>Pereira</surname><given-names>J. P.</given-names><suffix>Jr</suffix></name><name><surname>Moreira</surname><given-names>M. E.</given-names></name><etal/></person-group><article-title>Zika virus infection in pregnant women in Rio de Janeiro</article-title><source><italic toggle="yes">New England Journal of Medicine</italic></source><year>2016</year><volume>375</volume><issue>24</issue><fpage>2321</fpage><lpage>2334</lpage><pub-id pub-id-type="doi">10.1056/nejmoa1602412</pub-id><pub-id pub-id-type="other">2-s2.0-85019771888</pub-id><pub-id pub-id-type="pmid">26943629</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadhurst</surname><given-names>M. J.</given-names></name><name><surname>Brooks</surname><given-names>T. J. G.</given-names></name><name><surname>Pollock</surname><given-names>N. R.</given-names></name></person-group><article-title>Diagnosis of Ebola virus disease: past, present, and future</article-title><source><italic toggle="yes">Clinical Microbiology Reviews</italic></source><year>2016</year><volume>29</volume><issue>4</issue><fpage>773</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1128/cmr.00003-16</pub-id><pub-id pub-id-type="other">2-s2.0-84978906705</pub-id><pub-id pub-id-type="pmid">27413095</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>S. K.</given-names></name><name><surname>Sahoo</surname><given-names>M. K.</given-names></name><name><surname>Milligan</surname><given-names>S. B.</given-names></name><name><surname>Taylor</surname><given-names>N.</given-names></name><name><surname>Pinsky</surname><given-names>B. A.</given-names></name></person-group><article-title>Stability of Zika virus in urine: specimen processing considerations and implications for the detection of RNA targets in urine</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2017</year><volume>248</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2017.04.018</pub-id><pub-id pub-id-type="other">2-s2.0-85021255018</pub-id><pub-id pub-id-type="pmid">28472623</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Viboud</surname><given-names>C.</given-names></name></person-group><article-title>Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study</article-title><source><italic toggle="yes">The Lancet Digital Health</italic></source><year>2020</year><volume>2</volume><issue>4</issue><fpage>e201</fpage><lpage>e208</lpage><pub-id pub-id-type="doi">10.1016/s2589-7500(20)30026-1</pub-id><pub-id pub-id-type="pmid">32309796</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souf</surname><given-names>S.</given-names></name></person-group><article-title>Recent advances in diagnostic testing for viral infections</article-title><source><italic toggle="yes">Bioscience Horizons</italic></source><year>2016</year><volume>9</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1093/biohorizons/hzw010</pub-id><pub-id pub-id-type="other">2-s2.0-85016078868</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>R. S.</given-names></name><name><surname>Madhusudana</surname><given-names>S. N.</given-names></name></person-group><article-title>Laboratory diagnosis of human rabies: recent advances</article-title><source><italic toggle="yes">The Scientific World Journal</italic></source><year>2013</year><volume>2013</volume><fpage>10</fpage><pub-id pub-id-type="publisher-id">569712</pub-id><pub-id pub-id-type="doi">10.1155/2013/569712</pub-id><pub-id pub-id-type="other">2-s2.0-84890107369</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="book"><collab>World Health Organization (WHO)</collab><source><italic toggle="yes">Global Hepatitis Report 2017</italic></source><year>2017</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>World Health Organization</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris">http://apps.who.int/iris</ext-link></comment></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><collab>World Health Organization (WHO)</collab><article-title>Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO</article-title><year>2020</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/">http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/</ext-link></comment></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Recent advances and perspectives of nucleic acid detection for coronavirus</article-title><source><italic toggle="yes">Journal of Pharmaceutical Analysis</italic></source><year>2020</year><volume>10</volume><issue>2</issue><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.jpha.2020.02.010</pub-id><pub-id pub-id-type="pmid">32292623</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="book"><collab>World Health Organization (WHO)</collab><source><italic toggle="yes">Coronavirus Disease 2019 (COVID-19) Situation Report&#x02013; 156</italic></source><year>2020</year><publisher-loc>Geneva, Switzerland</publisher-loc><publisher-name>WHO</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/emergencies/diseases/novel-coronavirus-2019/situtaion-reports">http://www.who.int/emergencies/diseases/novel-coronavirus-2019/situtaion-reports</ext-link></comment></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>L. N.</given-names></name><name><surname>Blackstock</surname><given-names>D.</given-names></name><name><surname>Yates</surname><given-names>M. A.</given-names></name><name><surname>Mulchandani</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Detection of RNA viruses: current technologies and future perspectives</article-title><source><italic toggle="yes">Critical Reviews in Eukaryotic Gene Expression</italic></source><year>2013</year><volume>23</volume><issue>2</issue><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1615/critreveukaryotgeneexpr.2013006974</pub-id><pub-id pub-id-type="other">2-s2.0-84875882545</pub-id><pub-id pub-id-type="pmid">23582035</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Landry</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Detrick</surname><given-names>B.</given-names></name><name><surname>Schmitz</surname><given-names>J.</given-names></name><name><surname>Hamilton</surname><given-names>R.</given-names></name></person-group><article-title>Immunologic and molecular methods for viral diagnosis</article-title><source><italic toggle="yes">Manual of Molecular and Clinical Laboratory Immunology</italic></source><year>2016</year><edition>8th</edition><publisher-loc>Washington, DC, USA</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>538</fpage><lpage>549</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>T.</given-names></name><name><surname>Kennedy</surname><given-names>R.</given-names></name><name><surname>Daar</surname><given-names>A. S.</given-names></name><name><surname>Singer</surname><given-names>P. A.</given-names></name></person-group><article-title>Biotechnology to improve health in developing countries: a review</article-title><source><italic toggle="yes">Mem&#x000f3;rias Do Instituto Oswaldo Cruz</italic></source><year>2004</year><volume>99</volume><issue>4</issue><fpage>341</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1590/s0074-02762004000400001</pub-id><pub-id pub-id-type="other">2-s2.0-3242680777</pub-id><pub-id pub-id-type="pmid">15322621</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankaj</surname><given-names>K.</given-names></name></person-group><article-title>Methods for rapid virus identification and quantification</article-title><source><italic toggle="yes">Materials and Methods</italic></source><year>2013</year><volume>3</volume><fpage>p. 207</fpage><pub-id pub-id-type="doi">10.13070/mm.en.3.207</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Atmar</surname><given-names>R. L.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kaslow</surname><given-names>R. A.</given-names></name><name><surname>Stanberry</surname><given-names>L. R.</given-names></name><name><surname>Le Duc</surname><given-names>J. W.</given-names></name></person-group><article-title>Immunological detection and characterization</article-title><source><italic toggle="yes">Viral Infections of Humans: Epidemiology and Control</italic></source><year>2014</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Springer International Publishing AG</publisher-name><fpage>47</fpage><lpage>62</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S. C.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>R. J.</given-names></name><etal/></person-group><article-title>Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay</article-title><source><italic toggle="yes">Neuroimmunology and Neuroinflammation</italic></source><year>2014</year><volume>1</volume><issue>1</issue><fpage>24</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.4103/2347-8659.135572</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Chan</surname><given-names>K. H.</given-names></name><name><surname>Kang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</article-title><source><italic toggle="yes">Emerging Microbes and Infections</italic></source><year>2015</year><volume>4</volume><issue>4</issue><fpage>p. e26</fpage><pub-id pub-id-type="doi">10.1038/emi.2015.26</pub-id><pub-id pub-id-type="other">2-s2.0-84969667455</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>C. B.</given-names></name><name><surname>Mahony</surname><given-names>J. B.</given-names></name></person-group><article-title>Molecular detection of bacterial and viral pathogens&#x02013;Where do we go from here?</article-title><source><italic toggle="yes">Clinical Microbiology: Open Access</italic></source><year>2014</year><volume>3</volume><issue>6</issue><fpage>p. 175</fpage><pub-id pub-id-type="doi">10.4172/2327-5073.1000175</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canberk</surname><given-names>S.</given-names></name><name><surname>Longatto-Filho</surname><given-names>A.</given-names></name><name><surname>Schmitt</surname><given-names>F.</given-names></name></person-group><article-title>Molecular diagnosis of infectious diseases using cytological specimens</article-title><source><italic toggle="yes">Diagnostic Cytopathology</italic></source><year>2016</year><volume>44</volume><issue>2</issue><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1002/dc.23394</pub-id><pub-id pub-id-type="other">2-s2.0-84954381304</pub-id><pub-id pub-id-type="pmid">26620694</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodinka</surname><given-names>R. L.</given-names></name><name><surname>Kaiser</surname><given-names>L.</given-names></name></person-group><article-title>Point-counterpoint: is the era of viral culture over in the clinical microbiology laboratory?</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2013</year><volume>51</volume><issue>1</issue><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/jcm.02593-12</pub-id><pub-id pub-id-type="other">2-s2.0-84871705543</pub-id><pub-id pub-id-type="pmid">23052302</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ender</surname><given-names>A.</given-names></name><name><surname>Schmitt</surname><given-names>U. M.</given-names></name><name><surname>Endres</surname><given-names>W.</given-names></name><name><surname>Luz</surname><given-names>B.</given-names></name><name><surname>Sugg</surname><given-names>U.</given-names></name></person-group><article-title>Screening of blood donations for HIV-1 and HCV RNA by transcription-mediated amplification assay: one year experience</article-title><source><italic toggle="yes">Transfusion Medicine and Hemotherapy</italic></source><year>2004</year><volume>31</volume><issue>1</issue><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1159/000076982</pub-id><pub-id pub-id-type="other">2-s2.0-1342333631</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usawattanakul</surname><given-names>W.</given-names></name><name><surname>Jittmittraphap</surname><given-names>A.</given-names></name><name><surname>Endy</surname><given-names>T. P.</given-names></name><name><surname>Nisalak</surname><given-names>A.</given-names></name><name><surname>Tapchaisri</surname><given-names>P.</given-names></name><name><surname>Looareesuwan</surname><given-names>S.</given-names></name></person-group><article-title>Rapid detection of dengue viral RNA by nucleic acid sequence-based amplification (NASBA)</article-title><source><italic toggle="yes">Dengue Bulletin</italic></source><year>2003</year><volume>26</volume><fpage>125</fpage><lpage>130</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>R.</given-names></name><name><surname>White</surname><given-names>L. R.</given-names></name><name><surname>Stefanoff</surname><given-names>C. G.</given-names></name><etal/></person-group><article-title>Epstein-Barr Virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt&#x02019;s lymphoma</article-title><source><italic toggle="yes">Diagnostic Pathology</italic></source><year>2006</year><volume>1</volume><issue>1</issue><fpage>p. 17</fpage><pub-id pub-id-type="doi">10.1186/1746-1596-1-17</pub-id><pub-id pub-id-type="other">2-s2.0-33845387453</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maignan</surname><given-names>M.</given-names></name><name><surname>Viglino</surname><given-names>D.</given-names></name><name><surname>Hablot</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A/B virus at emergency department admission: a prospective evaluation during the 2017/2018 influenza season</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2019</year><volume>14</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e0216308</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0216308</pub-id><pub-id pub-id-type="other">2-s2.0-85065782657</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>V. M. D. P.</given-names></name><name><surname>Puri</surname><given-names>V.</given-names></name><name><surname>Oldfield</surname><given-names>LM.</given-names></name><name><surname>Shabman</surname><given-names>R. S.</given-names></name><name><surname>Tan</surname><given-names>G. S.</given-names></name><name><surname>Pickett</surname><given-names>B. E.</given-names></name></person-group><article-title>Optimization of qRT-PCR assay for zika virus detection in human serum and urine</article-title><source><italic toggle="yes">Virus Research</italic></source><year>2019</year><volume>263</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2019.01.013</pub-id><pub-id pub-id-type="other">2-s2.0-85061541789</pub-id><pub-id pub-id-type="pmid">30742853</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biava</surname><given-names>M.</given-names></name><name><surname>Colavita</surname><given-names>F.</given-names></name><name><surname>Marzorati</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola virus</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2018</year><volume>252</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2017.11.009</pub-id><pub-id pub-id-type="other">2-s2.0-85034808122</pub-id><pub-id pub-id-type="pmid">29170019</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V. M.</given-names></name><name><surname>Landt</surname><given-names>O.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR</article-title><source><italic toggle="yes">Eurosurveillance</italic></source><year>2020</year><volume>25</volume><issue>3</issue><pub-id pub-id-type="publisher-id">2000045</pub-id><pub-id pub-id-type="doi">10.2807/1560-7917.es.2020.25.3.2000045</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramamurthy</surname><given-names>M.</given-names></name><name><surname>Alexander</surname><given-names>M.</given-names></name><name><surname>Aaron</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Comparison of a conventional polymerase chain reaction with real-time polymerase chain reaction for the detection of neurotropic viruses in cerebrospinal fluid samples</article-title><source><italic toggle="yes">Indian Journal of Medical Microbiology</italic></source><year>2011</year><volume>29</volume><issue>2</issue><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.4103/0255-0857.81777</pub-id><pub-id pub-id-type="other">2-s2.0-79959253243</pub-id><pub-id pub-id-type="pmid">21654102</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>I. M.</given-names></name></person-group><article-title>Real-time PCR in the microbiology laboratory</article-title><source><italic toggle="yes">Clinical Microbiology and Infection</italic></source><year>2004</year><volume>10</volume><issue>3</issue><fpage>190</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1111/j.1198-743x.2004.00722.x</pub-id><pub-id pub-id-type="other">2-s2.0-1642318064</pub-id><pub-id pub-id-type="pmid">15008940</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashir</surname><given-names>J.</given-names></name><name><surname>Yaqinuddin</surname><given-names>A.</given-names></name></person-group><article-title>Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19</article-title><source><italic toggle="yes">Medical Hypotheses</italic></source><year>2020</year><volume>141</volume><pub-id pub-id-type="publisher-id">109786</pub-id><pub-id pub-id-type="doi">10.1016/j.mehy.2020.109786</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauri</surname><given-names>A.</given-names></name><name><surname>Mariani</surname><given-names>P. O.</given-names></name></person-group><article-title>Potentials and limitations of molecular diagnostic methods in food safety</article-title><source><italic toggle="yes">Genes and Nutrition</italic></source><year>2009</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s12263-008-0106-1</pub-id><pub-id pub-id-type="other">2-s2.0-77549083421</pub-id><pub-id pub-id-type="pmid">19067016</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorburn</surname><given-names>F.</given-names></name><name><surname>Bennett</surname><given-names>S.</given-names></name><name><surname>Modha</surname><given-names>S.</given-names></name><name><surname>Murdoch</surname><given-names>D.</given-names></name><name><surname>Gunson</surname><given-names>R.</given-names></name><name><surname>Murcia</surname><given-names>P. R.</given-names></name></person-group><article-title>The use of next generation sequencing in the diagnosis and typing of respiratory infections</article-title><source><italic toggle="yes">Journal of Clinical Virology</italic></source><year>2015</year><volume>69</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.06.082</pub-id><pub-id pub-id-type="other">2-s2.0-84937895183</pub-id><pub-id pub-id-type="pmid">26209388</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakhaie</surname><given-names>M.</given-names></name><name><surname>Soleimanjahi</surname><given-names>H.</given-names></name><name><surname>Mollaie</surname><given-names>H.</given-names></name><name><surname>Arabzadeh</surname><given-names>S.</given-names></name></person-group><article-title>Development of multiplex reverse transcription-polymerase chain reaction for simultaneous detection of influenza A, B and adenoviruses</article-title><source><italic toggle="yes">Iranian Journal of Pathology</italic></source><year>2018</year><volume>13</volume><issue>1</issue><fpage>54</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">29731796</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boppana</surname><given-names>S. B.</given-names></name><name><surname>Ross</surname><given-names>S. A.</given-names></name><name><surname>Shimamura</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Saliva polymerase-chain-reaction assay for Cytomegalovirus screening in newborns</article-title><source><italic toggle="yes">New England Journal of Medicine</italic></source><year>2011</year><volume>364</volume><issue>22</issue><fpage>2111</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1056/nejmoa1006561</pub-id><pub-id pub-id-type="other">2-s2.0-79957877087</pub-id><pub-id pub-id-type="pmid">21631323</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhullar</surname><given-names>S. S.</given-names></name><name><surname>Chandak</surname><given-names>N. H.</given-names></name><name><surname>Purohit</surname><given-names>H. J.</given-names></name><name><surname>Taori</surname><given-names>G. M.</given-names></name><name><surname>Daginawala</surname><given-names>H. F.</given-names></name><name><surname>Kashyap</surname><given-names>R. S.</given-names></name></person-group><article-title>Determination of viral load by quantitative real-time PCR in herpes simplex encephalitis patients</article-title><source><italic toggle="yes">Intervirology</italic></source><year>2014</year><volume>57</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1159/000351521</pub-id><pub-id pub-id-type="other">2-s2.0-84889817460</pub-id><pub-id pub-id-type="pmid">23988484</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>B. D.</given-names></name></person-group><source><italic toggle="yes">Biotechnology: Expanding Horizons</italic></source><year>2008</year><edition>2nd</edition><publisher-loc>Ludhiana, India</publisher-loc><publisher-name>Kalyani Publisher</publisher-name><fpage>p. 815</fpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fakruddin</surname><given-names>M. D.</given-names></name><name><surname>Mazumdar</surname><given-names>R. M.</given-names></name><name><surname>Chowdhury</surname><given-names>A.</given-names></name><name><surname>Bin Mannan</surname><given-names>K. S.</given-names></name></person-group><article-title>Nucleic acid sequence based amplification (NASBA)-prospects and applications</article-title><source><italic toggle="yes">International Journal of Life science and Pharma Research</italic></source><year>2012</year><volume>2</volume><issue>1</issue><fpage>106</fpage><lpage>121</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sooknanan</surname><given-names>R.</given-names></name><name><surname>Malek</surname><given-names>L. T.</given-names></name><name><surname>van Gemen</surname><given-names>B.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Wiedbrauk</surname><given-names>D. L.</given-names></name><name><surname>Farkas</surname><given-names>D. H.</given-names></name></person-group><article-title>Nucleic acid sequence-based amplification</article-title><source><italic toggle="yes">Methods for Virus Detection</italic></source><year>1995</year><publisher-loc>San Diego, CA, USA</publisher-loc><publisher-name>Academic Press, Inc</publisher-name><fpage>262</fpage><lpage>271</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayele</surname><given-names>W.</given-names></name><name><surname>Pollakis</surname><given-names>G.</given-names></name><name><surname>Abebe</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C&#x02019; infections in Ethiopia</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>4</issue><fpage>1534</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1128/jcm.42.4.1534-1541.2004</pub-id><pub-id pub-id-type="other">2-s2.0-16544368707</pub-id><pub-id pub-id-type="pmid">15071000</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paryan</surname><given-names>M.</given-names></name><name><surname>Forouzandeh</surname><given-names>M. M.</given-names></name><name><surname>Kia</surname><given-names>V.</given-names></name><name><surname>Mohammadi-Yeganeh</surname><given-names>S.</given-names></name><name><surname>Raz</surname><given-names>A.</given-names></name><name><surname>Mirab Samiee</surname><given-names>S.</given-names></name></person-group><article-title>A simple and rapid method for the detection of HIV-1/HCV in co-infected patients</article-title><source><italic toggle="yes">Iranian Journal of Biotechnology</italic></source><year>2013</year><volume>11</volume><issue>2</issue><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.5812/ijb.10717</pub-id><pub-id pub-id-type="other">2-s2.0-84884698222</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoos</surname><given-names>J.</given-names></name><name><surname>Peters</surname><given-names>R. M.</given-names></name><name><surname>Tabatabai</surname><given-names>J.</given-names></name><name><surname>Grulich-Henn</surname><given-names>J.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name><name><surname>Pfeil</surname><given-names>J.</given-names></name></person-group><article-title>Reverse-transcription loop-mediated isothermal amplification for rapid detection of respiratory syncytial virus directly from nasopharyngeal swabs</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2017</year><volume>242</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2017.01.006</pub-id><pub-id pub-id-type="other">2-s2.0-85009986551</pub-id><pub-id pub-id-type="pmid">28093275</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bista</surname><given-names>B. R.</given-names></name><name><surname>Ishwad</surname><given-names>C.</given-names></name><name><surname>Wadowsky</surname><given-names>R. M.</given-names></name><etal/></person-group><article-title>Development of a loop-mediated isothermal amplification assay for rapid detection of BK virus</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2007</year><volume>45</volume><issue>5</issue><fpage>1581</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1128/jcm.01024-06</pub-id><pub-id pub-id-type="other">2-s2.0-34248595508</pub-id><pub-id pub-id-type="pmid">17314224</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karthik</surname><given-names>K.</given-names></name><name><surname>Rathore</surname><given-names>R.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><etal/></person-group><article-title>New closed tube loop mediated isothermal amplification assay for prevention of product cross-contamination</article-title><source><italic toggle="yes">MethodsX</italic></source><year>2014</year><volume>1</volume><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/j.mex.2014.08.009</pub-id><pub-id pub-id-type="other">2-s2.0-84907535065</pub-id><pub-id pub-id-type="pmid">26150945</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notomi</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Tomita</surname><given-names>N.</given-names></name><name><surname>Kanda</surname><given-names>H.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects</article-title><source><italic toggle="yes">Journal of Microbiology</italic></source><year>2015</year><volume>53</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/s12275-015-4656-9</pub-id><pub-id pub-id-type="other">2-s2.0-84934922809</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullis</surname><given-names>K. B.</given-names></name><name><surname>Faloona</surname><given-names>F. A.</given-names></name></person-group><article-title>Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction</article-title><source><italic toggle="yes">Methods in Enzymology</italic></source><year>1987</year><volume>155</volume><fpage>335</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(87)55023-6</pub-id><pub-id pub-id-type="other">2-s2.0-0023461268</pub-id><pub-id pub-id-type="pmid">3431465</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobo</surname><given-names>F.</given-names></name></person-group><article-title>Application of molecular diagnostic techniques for viral testing</article-title><source><italic toggle="yes">The Open Virology Journal</italic></source><year>2012</year><volume>6</volume><issue>1</issue><fpage>104</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.2174/1874357901206010104</pub-id><pub-id pub-id-type="pmid">23248732</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>M.</given-names></name><name><surname>Sheu</surname><given-names>T. G.</given-names></name><name><surname>Gubareva</surname><given-names>L. V.</given-names></name><name><surname>Mishin</surname><given-names>V. P.</given-names></name></person-group><article-title>Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2011</year><volume>49</volume><issue>4</issue><fpage>1307</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1128/jcm.02424-10</pub-id><pub-id pub-id-type="other">2-s2.0-79953858651</pub-id><pub-id pub-id-type="pmid">21307217</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demmler</surname><given-names>G. J.</given-names></name><name><surname>Buffone</surname><given-names>G. J.</given-names></name><name><surname>Schimbor</surname><given-names>C. M.</given-names></name><name><surname>May</surname><given-names>R. A.</given-names></name></person-group><article-title>Detection of Cytomegalovirus in urine from newborns by using polymerase chain reaction DNA Amplification</article-title><source><italic toggle="yes">Journal of Infectious Diseases</italic></source><year>1988</year><volume>158</volume><issue>6</issue><fpage>1177</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1093/infdis/158.6.1177</pub-id><pub-id pub-id-type="other">2-s2.0-0024214078</pub-id><pub-id pub-id-type="pmid">2848897</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myerson</surname><given-names>D.</given-names></name><name><surname>Lingenfelter</surname><given-names>P. A.</given-names></name><name><surname>Gleaves</surname><given-names>C. A.</given-names></name><name><surname>Meyers</surname><given-names>J. D.</given-names></name><name><surname>Bowden</surname><given-names>R. A.</given-names></name></person-group><article-title>Diagnosis of Cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid</article-title><source><italic toggle="yes">American Journal of Clinical Pathology</italic></source><year>1993</year><volume>100</volume><issue>4</issue><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1093/ajcp/100.4.407</pub-id><pub-id pub-id-type="other">2-s2.0-0027430075</pub-id><pub-id pub-id-type="pmid">8213636</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaramurthy</surname><given-names>R.</given-names></name><name><surname>Dhodapkar</surname><given-names>R.</given-names></name><name><surname>Kaliaperumal</surname><given-names>S.</given-names></name><name><surname>Harish</surname><given-names>B. N.</given-names></name></person-group><article-title>Investigational approach to adenoviral conjunctivitis: comparison of three diagnostic tests using a Bayesian latent class model</article-title><source><italic toggle="yes">The Journal of Infection in Developing Countries</italic></source><year>2018</year><volume>12</volume><issue>1</issue><fpage>043</fpage><lpage>051</lpage><pub-id pub-id-type="doi">10.3855/jidc.9439</pub-id><pub-id pub-id-type="other">2-s2.0-85041498832</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>F.</given-names></name><name><surname>Falkner</surname><given-names>F. G.</given-names></name><name><surname>Dorner</surname><given-names>F.</given-names></name><name><surname>H&#x000e4;mmerle</surname><given-names>T.</given-names></name></person-group><article-title>Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection</article-title><source><italic toggle="yes">Applied and Environmental Microbiology</italic></source><year>2001</year><volume>67</volume><issue>6</issue><fpage>2837</fpage><lpage>2839</lpage><pub-id pub-id-type="doi">10.1128/aem.67.6.2837-2839.2001</pub-id><pub-id pub-id-type="other">2-s2.0-0035379562</pub-id><pub-id pub-id-type="pmid">11375203</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falsey</surname><given-names>A. R.</given-names></name><name><surname>Formica</surname><given-names>M. A.</given-names></name><name><surname>Walsh</surname><given-names>E. E.</given-names></name></person-group><article-title>Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2002</year><volume>40</volume><issue>3</issue><fpage>817</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1128/jcm.40.3.817-820.2002</pub-id><pub-id pub-id-type="other">2-s2.0-0036196503</pub-id><pub-id pub-id-type="pmid">11880399</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Formenty</surname><given-names>P.</given-names></name><name><surname>Leroy</surname><given-names>E. M.</given-names></name><name><surname>Epelboin</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo</article-title><source><italic toggle="yes">Clinical Infectious Diseases</italic></source><year>2006</year><volume>42</volume><issue>11</issue><fpage>1521</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1086/503836</pub-id><pub-id pub-id-type="other">2-s2.0-33646749925</pub-id><pub-id pub-id-type="pmid">16652308</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>R.</given-names></name><name><surname>Fockler</surname><given-names>C.</given-names></name><name><surname>Dollinger</surname><given-names>G.</given-names></name><name><surname>Watson</surname><given-names>R.</given-names></name></person-group><article-title>Kinetic PCR analysis: real-time monitoring of DNA amplification reactions</article-title><source><italic toggle="yes">Nature Biotechnology</italic></source><year>1993</year><volume>11</volume><issue>9</issue><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1038/nbt0993-1026</pub-id><pub-id pub-id-type="other">2-s2.0-15744381713</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>P. M.</given-names></name><name><surname>Abramson</surname><given-names>R. D.</given-names></name><name><surname>Watson</surname><given-names>R.</given-names></name><name><surname>Gelfand</surname><given-names>D. H.</given-names></name></person-group><article-title>Detection of specific polymerase chain reaction product by utilizing the 5&#x02032;-3&#x02032; exonuclease activity of Thermus aquaticus DNA polymerase</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source><year>1991</year><volume>88</volume><issue>16</issue><fpage>7276</fpage><lpage>7280</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.16.7276</pub-id><pub-id pub-id-type="other">2-s2.0-0025861818</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espy</surname><given-names>M. J.</given-names></name><name><surname>Uhl</surname><given-names>J. R.</given-names></name><name><surname>Sloan</surname><given-names>L. M.</given-names></name><etal/></person-group><article-title>Real-time PCR in clinical microbiology: applications for routine laboratory testing</article-title><source><italic toggle="yes">Clinical Microbiology Reviews</italic></source><year>2006</year><volume>19</volume><issue>1</issue><fpage>165</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1128/cmr.19.1.165-256.2006</pub-id><pub-id pub-id-type="other">2-s2.0-31544469804</pub-id><pub-id pub-id-type="pmid">16418529</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gartzonika</surname><given-names>C.</given-names></name><name><surname>Vrioni</surname><given-names>G.</given-names></name><name><surname>Priavali</surname><given-names>E.</given-names></name><name><surname>Pappas</surname><given-names>G.</given-names></name><name><surname>Levidiotou</surname><given-names>S.</given-names></name></person-group><article-title>Utility of Real-time PCR in the diagnosis of primary Epstein-Barr virus infection</article-title><source><italic toggle="yes">Journal of Medical Microbiology and Diagnosis</italic></source><year>2012</year><volume>2</volume><issue>1</issue><fpage>p. 118</fpage><pub-id pub-id-type="doi">10.4172/2161-0703.1000118</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Rapid diagnosis of human adenovirus B, C and E in the respiratory tract using multiplex quantitative polymerase chain reaction</article-title><source><italic toggle="yes">Molecular Medicine Reports</italic></source><year>2018</year><volume>18</volume><issue>3</issue><fpage>2889</fpage><lpage>2897</lpage><pub-id pub-id-type="doi">10.3892/mmr.2018.9253</pub-id><pub-id pub-id-type="other">2-s2.0-85054936395</pub-id><pub-id pub-id-type="pmid">30015894</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>F. Z.</given-names></name><name><surname>Shen</surname><given-names>X. X.</given-names></name><name><surname>Zhao</surname><given-names>M. C.</given-names></name><etal/></person-group><article-title>A triplex quantitative real-time PCR assay for differential detection of human adenovirus serotypes 2, 3 and 7</article-title><source><italic toggle="yes">Virology Journal</italic></source><year>2018</year><volume>15</volume><fpage>p. 81</fpage><pub-id pub-id-type="doi">10.1186/s12985-018-0983-x</pub-id><pub-id pub-id-type="other">2-s2.0-85046293309</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.-H.</given-names></name><name><surname>Lai</surname><given-names>J.-P.</given-names></name><name><surname>Douglas</surname><given-names>S. D.</given-names></name><name><surname>Metzger</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>X.-H.</given-names></name><name><surname>Ho</surname><given-names>W.-Z.</given-names></name></person-group><article-title>Real-time RT-PCR for quantitation of hepatitis C virus RNA</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2002</year><volume>102</volume><issue>1-2</issue><fpage>119</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/s0166-0934(02)00007-1</pub-id><pub-id pub-id-type="other">2-s2.0-0036189079</pub-id><pub-id pub-id-type="pmid">11879700</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watzinger</surname><given-names>F.</given-names></name><name><surname>Suda</surname><given-names>M.</given-names></name><name><surname>Preuner</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>11</issue><fpage>5189</fpage><lpage>5198</lpage><pub-id pub-id-type="doi">10.1128/jcm.42.11.5189-5198.2004</pub-id><pub-id pub-id-type="other">2-s2.0-8644237322</pub-id><pub-id pub-id-type="pmid">15528714</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Tu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Real-time PCR for detecting circulating dengue virus in the Guangdong Province of China in 2006</article-title><source><italic toggle="yes">Journal of Medical Microbiology</italic></source><year>2008</year><volume>57</volume><issue>12</issue><fpage>1547</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.2008/003418-0</pub-id><pub-id pub-id-type="other">2-s2.0-57749209661</pub-id><pub-id pub-id-type="pmid">19018028</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueudin</surname><given-names>M.</given-names></name><name><surname>Leoz</surname><given-names>M.</given-names></name><name><surname>Lem&#x000e9;e</surname><given-names>V.</given-names></name><etal/></person-group><article-title>A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2012</year><volume>50</volume><issue>3</issue><fpage>831</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1128/jcm.05669-11</pub-id><pub-id pub-id-type="other">2-s2.0-84857377916</pub-id><pub-id pub-id-type="pmid">22170927</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behzadi</surname><given-names>M. A.</given-names></name><name><surname>Ziyaeyan</surname><given-names>M.</given-names></name><name><surname>Alborzi</surname><given-names>A.</given-names></name></person-group><article-title>A diagnostic one-step real-time reverse transcription polymerase chain reaction method for accurate detection of influenza virus type A</article-title><source><italic toggle="yes">Archives of Medical Science</italic></source><year>2016</year><volume>12</volume><issue>6</issue><fpage>1286</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.5114/aoms.2016.62914</pub-id><pub-id pub-id-type="other">2-s2.0-84992694511</pub-id><pub-id pub-id-type="pmid">27904520</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000fa;nior</surname><given-names>R. B. M.</given-names></name><name><surname>Carney</surname><given-names>S.</given-names></name><name><surname>Goldemberg</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Detection of respiratory viruses by real-time polymerase chain reaction in outpatients with acute respiratory infection</article-title><source><italic toggle="yes">Mem&#x000f3;rias do Instituto Oswaldo Cruz</italic></source><year>2014</year><volume>109</volume><issue>6</issue><fpage>716</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1590/0074-0276140046</pub-id><pub-id pub-id-type="other">2-s2.0-84907191585</pub-id><pub-id pub-id-type="pmid">25317699</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi-Yeganeh</surname><given-names>S.</given-names></name><name><surname>Paryan</surname><given-names>M.</given-names></name><name><surname>Mirab Samiee</surname><given-names>S.</given-names></name><name><surname>Kia</surname><given-names>V.</given-names></name><name><surname>Rezvan</surname><given-names>H.</given-names></name></person-group><article-title>Molecular beacon probes-base multiplex NASBA Real-time for detection of HIV-1 and HCV</article-title><source><italic toggle="yes">Iranian Journal of Microbiology</italic></source><year>2012</year><volume>4</volume><issue>2</issue><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">22973469</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>A. C.-H.</given-names></name><name><surname>Vatcher</surname><given-names>G.</given-names></name><name><surname>Yue</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Nucleic acid-based diagnostics for infectious diseases in public health affairs</article-title><source><italic toggle="yes">Frontiers of Medicine</italic></source><year>2012</year><volume>6</volume><issue>2</issue><fpage>173</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s11684-012-0195-5</pub-id><pub-id pub-id-type="other">2-s2.0-84863593546</pub-id><pub-id pub-id-type="pmid">22660977</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercier&#x02010;Delarue</surname><given-names>S.</given-names></name><name><surname>Vray</surname><given-names>M.</given-names></name><name><surname>Plantier</surname><given-names>J. C.</given-names></name><etal/></person-group><article-title>Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2014</year><volume>52</volume><issue>1</issue><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1128/jcm.01848-13</pub-id><pub-id pub-id-type="other">2-s2.0-84891373959</pub-id><pub-id pub-id-type="pmid">24131691</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C.</given-names></name><name><surname>Telles</surname><given-names>J.-N.</given-names></name><name><surname>Corden</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Development and validation of a commercial real-time NASBA assay for the rapid confirmation of influenza A H5N1 virus in clinical samples</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2010</year><volume>170</volume><issue>1-2</issue><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2010.09.014</pub-id><pub-id pub-id-type="other">2-s2.0-78249267257</pub-id><pub-id pub-id-type="pmid">20863852</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swenson</surname><given-names>P. D.</given-names></name><name><surname>El-Sabaeny</surname><given-names>A.</given-names></name><name><surname>Thomas-Moricz</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Evaluation of a transcription mediated amplification assay for detection of herpes simplex virus types 1 and 2 mRNA in clinical specimens</article-title><source><italic toggle="yes">Journal of Clinical Virology</italic></source><year>2016</year><volume>80</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2016.04.023</pub-id><pub-id pub-id-type="other">2-s2.0-84966397910</pub-id><pub-id pub-id-type="pmid">27175478</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I. S.</given-names></name><name><surname>Choi</surname><given-names>D. H.</given-names></name><name><surname>Lim</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Real-time nucleic acid sequence based amplification (Real-time NASBA) for detection of Norovirus</article-title><source><italic toggle="yes">Journal of Experimental and Biomedical Sciences</italic></source><year>2011</year><volume>17</volume><issue>3</issue><fpage>191</fpage><lpage>196</lpage></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C.</given-names></name><name><surname>Valappil</surname><given-names>M.</given-names></name><name><surname>Corden</surname><given-names>S.</given-names></name><name><surname>Westmoreland</surname><given-names>D.</given-names></name></person-group><article-title>Enhanced clinical utility of the NucliSens EasyQ RSV A+B assay for rapid detection of respiratory syncytial virus in clinical samples</article-title><source><italic toggle="yes">European Journal of Clinical Microbiology and Infectious Diseases</italic></source><year>2006</year><volume>25</volume><issue>3</issue><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1007/s10096-006-0112-4</pub-id><pub-id pub-id-type="other">2-s2.0-33645061247</pub-id><pub-id pub-id-type="pmid">16534566</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notomi</surname><given-names>T.</given-names></name><name><surname>Okayama</surname><given-names>H.</given-names></name><name><surname>Masubuchi</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Loop-mediated isothermal amplification of DNA</article-title><source><italic toggle="yes">Nucleic Acids Research</italic></source><year>2000</year><volume>28</volume><issue>12</issue><fpage>p. E63</fpage><pub-id pub-id-type="doi">10.1093/nar/28.12.e63</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagamine</surname><given-names>K.</given-names></name><name><surname>Hase</surname><given-names>T.</given-names></name><name><surname>Notomi</surname><given-names>T.</given-names></name></person-group><article-title>Accelerated reaction by loop-mediated isothermal amplification using loop primers</article-title><source><italic toggle="yes">Molecular and Cellular Probes</italic></source><year>2002</year><volume>16</volume><issue>3</issue><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1006/mcpr.2002.0415</pub-id><pub-id pub-id-type="other">2-s2.0-0036599262</pub-id><pub-id pub-id-type="pmid">12144774</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuta</surname><given-names>S.</given-names></name><name><surname>Iida</surname><given-names>T.</given-names></name><name><surname>Mizukami</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Detection of Japanese yam mosaic virus by RT-LAMP</article-title><source><italic toggle="yes">Archives of Virology</italic></source><year>2003</year><volume>148</volume><issue>9</issue><fpage>1713</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1007/s00705-003-0134-5</pub-id><pub-id pub-id-type="other">2-s2.0-0141563272</pub-id><pub-id pub-id-type="pmid">14505084</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becherer</surname><given-names>L.</given-names></name><name><surname>Borst</surname><given-names>N.</given-names></name><name><surname>Bakheit</surname><given-names>M.</given-names></name><name><surname>Frischmann</surname><given-names>S.</given-names></name><name><surname>Zengerle</surname><given-names>R.</given-names></name><name><surname>von Stetten</surname><given-names>F.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification (LAMP) - review and classification of methods for sequence specific detection</article-title><source><italic toggle="yes">Analytical Methods</italic></source><year>2020</year><volume>12</volume><issue>6</issue><fpage>717</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1039/c9ay02246e</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>N.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Kanda</surname><given-names>H.</given-names></name><name><surname>Notomi</surname><given-names>T.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products</article-title><source><italic toggle="yes">Nature Protocols</italic></source><year>2008</year><volume>3</volume><issue>5</issue><fpage>877</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.57</pub-id><pub-id pub-id-type="other">2-s2.0-43149084823</pub-id><pub-id pub-id-type="pmid">18451795</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>S. J. R. D.</given-names></name><name><surname>Pardee</surname><given-names>K.</given-names></name><name><surname>Pena</surname><given-names>L.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification (LAMP) for the diagnosis of Zika virus: a review</article-title><source><italic toggle="yes">Viruses</italic></source><year>2020</year><volume>12</volume><issue>1</issue><fpage>p. 19</fpage><pub-id pub-id-type="doi">10.3390/v12010019</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teoh</surname><given-names>B. T.</given-names></name><name><surname>Sam</surname><given-names>S. S.</given-names></name><name><surname>Tan</surname><given-names>K. K.</given-names></name><etal/></person-group><article-title>Detection of dengue viruses using reverse transcription-loop-mediated isothermal amplification</article-title><source><italic toggle="yes">BMC Infectious Diseases</italic></source><year>2013</year><volume>13</volume><fpage>p. 387</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-13-387</pub-id><pub-id pub-id-type="other">2-s2.0-84882329198</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A. K.</given-names></name><name><surname>Balne</surname><given-names>P. K.</given-names></name><name><surname>Reddy</surname><given-names>R. K.</given-names></name><name><surname>Mathai</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>I.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification assay for the diagnosis of retinitis caused by herpes simplex virus-1</article-title><source><italic toggle="yes">Clinical Microbiology and Infection</italic></source><year>2011</year><volume>17</volume><issue>2</issue><fpage>210</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03216.x</pub-id><pub-id pub-id-type="other">2-s2.0-78751606366</pub-id><pub-id pub-id-type="pmid">20298270</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Fang</surname><given-names>M.-X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Lou</surname><given-names>G.-Q.</given-names></name><name><surname>Lu</surname><given-names>H.-J.</given-names></name><name><surname>Wu</surname><given-names>N.-P.</given-names></name></person-group><article-title>Detection of hepatitis C virus by an improved loop-mediated isothermal amplification assay</article-title><source><italic toggle="yes">Archives of Virology</italic></source><year>2011</year><volume>156</volume><issue>8</issue><fpage>1387</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1007/s00705-011-1001-4</pub-id><pub-id pub-id-type="other">2-s2.0-79960894204</pub-id><pub-id pub-id-type="pmid">21562883</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirato</surname><given-names>K.</given-names></name><name><surname>Yano</surname><given-names>T.</given-names></name><name><surname>Senba</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)</article-title><source><italic toggle="yes">Virology Journal</italic></source><year>2014</year><volume>11</volume><issue>1</issue><fpage>p. 139</fpage><pub-id pub-id-type="doi">10.1186/1743-422x-11-139</pub-id><pub-id pub-id-type="other">2-s2.0-84906559641</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziros</surname><given-names>P. G.</given-names></name><name><surname>Kokkinos</surname><given-names>P. A.</given-names></name><name><surname>Allard</surname><given-names>A.</given-names></name><name><surname>Vantarakis</surname><given-names>A.</given-names></name></person-group><article-title>Development and evaluation of a loop-mediated isothermal amplification assay for the detection of adenovirus 40 and 41</article-title><source><italic toggle="yes">Food and Environmental Virology</italic></source><year>2015</year><volume>7</volume><issue>3</issue><fpage>276</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1007/s12560-015-9182-8</pub-id><pub-id pub-id-type="other">2-s2.0-84938690461</pub-id><pub-id pub-id-type="pmid">25649029</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>S.</given-names></name><name><surname>Shibata</surname><given-names>Y.</given-names></name><name><surname>Kawada</surname><given-names>J.-i.</given-names></name><etal/></person-group><article-title>Rapid detection of Epstein-Barr virus DNA by loop-mediated isothermal amplification method</article-title><source><italic toggle="yes">Journal of Clinical Virology</italic></source><year>2006</year><volume>37</volume><issue>2</issue><fpage>128</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2006.07.011</pub-id><pub-id pub-id-type="other">2-s2.0-33748954455</pub-id><pub-id pub-id-type="pmid">16973412</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A. K.</given-names></name><name><surname>Balne</surname><given-names>P. K.</given-names></name><name><surname>Reddy</surname><given-names>R. K.</given-names></name><name><surname>Mathai</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>I.</given-names></name></person-group><article-title>Development and evaluation of loop-mediated isothermal amplification assay for rapid and inexpensive detection of Cytomegalovirus DNA in vitreous specimens from suspected cases of viral retinitis</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2010</year><volume>48</volume><issue>6</issue><fpage>2050</fpage><lpage>2052</lpage><pub-id pub-id-type="doi">10.1128/jcm.02248-09</pub-id><pub-id pub-id-type="other">2-s2.0-77952925806</pub-id><pub-id pub-id-type="pmid">20351207</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W. E.</given-names></name><name><surname>Lim</surname><given-names>B.</given-names></name><name><surname>Hsu</surname><given-names>C. C.</given-names></name><etal/></person-group><article-title>RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2</article-title><source><italic toggle="yes">Microbial Biotechnology</italic></source><year>2020</year><volume>13</volume><issue>4</issue><fpage>950</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13586</pub-id><pub-id pub-id-type="pmid">32333644</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wan</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Development of a novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2</article-title><source><italic toggle="yes">Virologica Sinica</italic></source><year>2020</year><volume>35</volume><issue>3</issue><fpage>344</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1007/s12250-020-00218-1</pub-id><pub-id pub-id-type="pmid">32239445</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>Y. H.</given-names></name><name><surname>Um</surname><given-names>J.</given-names></name><name><surname>Antigua</surname><given-names>K. J. C.</given-names></name><etal/></person-group><article-title>Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2</article-title><source><italic toggle="yes">Emerging Microbes and Infections</italic></source><year>2020</year><volume>9</volume><issue>1</issue><fpage>998</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1756698</pub-id><pub-id pub-id-type="pmid">32306853</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosaki</surname><given-names>Y.</given-names></name><name><surname>Magassouba</surname><given-names>N.</given-names></name><name><surname>Oloniniyi</surname><given-names>O. K.</given-names></name><etal/></person-group><article-title>Development and evaluation of reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay coupled with a portable device for rapid diagnosis of Ebola virus disease in Guinea</article-title><source><italic toggle="yes">PLoS Neglected Tropical Diseases</italic></source><year>2016</year><volume>10</volume><issue>2</issue><pub-id pub-id-type="publisher-id">e0004472</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0004472</pub-id><pub-id pub-id-type="other">2-s2.0-84959288239</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeinoddini</surname><given-names>M.</given-names></name><name><surname>Monazah</surname><given-names>A.</given-names></name><name><surname>Saeedinia</surname><given-names>A. R.</given-names></name></person-group><article-title>Comparison between RT-PCR, NASBA and RT-LAMP methods for detection of Coxsackievirus B3</article-title><source><italic toggle="yes">Biomacromolecular Journal</italic></source><year>2017</year><volume>3</volume><issue>2</issue><fpage>100</fpage><lpage>106</lpage></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.-j.</given-names></name><name><surname>Shu</surname><given-names>Y.-l.</given-names></name><name><surname>Nie</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Visual detection of pandemic influenza A H1N1 Virus 2009 by reverse-transcription loop-mediated isothermal amplification with hydroxynaphthol blue dye</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2010</year><volume>167</volume><issue>2</issue><fpage>214</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2010.03.027</pub-id><pub-id pub-id-type="other">2-s2.0-77953537088</pub-id><pub-id pub-id-type="pmid">20381535</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>D. T.</given-names></name><name><surname>Le</surname><given-names>M. T. Q.</given-names></name><name><surname>Vuong</surname><given-names>C. D.</given-names></name><name><surname>Hasebe</surname><given-names>F.</given-names></name><name><surname>Morita</surname><given-names>K.</given-names></name></person-group><article-title>An updated loop-mediated isothermal amplification method for rapid diagnosis of H5N1 avian influenza viruses</article-title><source><italic toggle="yes">Tropical Medicine and Health</italic></source><year>2011</year><volume>39</volume><issue>1</issue><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2149/tmh.2010-21</pub-id><pub-id pub-id-type="other">2-s2.0-79953899928</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kargar</surname><given-names>M.</given-names></name><name><surname>Askari</surname><given-names>A.</given-names></name><name><surname>Doosti</surname><given-names>A.</given-names></name><name><surname>Ghorbani-Dalini</surname><given-names>S.</given-names></name></person-group><article-title>Loop-mediated isothermal amplification assay for rapid detection of hepatitis C virus</article-title><source><italic toggle="yes">Indian Journal of Virology</italic></source><year>2012</year><volume>23</volume><issue>1</issue><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s13337-012-0067-2</pub-id><pub-id pub-id-type="other">2-s2.0-84865959349</pub-id><pub-id pub-id-type="pmid">23729997</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>D. L.</given-names></name><name><surname>Sullivan</surname><given-names>V.</given-names></name><name><surname>Owen</surname><given-names>S. M.</given-names></name><name><surname>Curtis</surname><given-names>K. A.</given-names></name></person-group><article-title>Detection of acute HIV-1 infection by RT-LAMP</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2015</year><volume>10</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e0126609</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0126609</pub-id><pub-id pub-id-type="other">2-s2.0-84930646352</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabalza</surname><given-names>M.</given-names></name><name><surname>Yasmin</surname><given-names>R.</given-names></name><name><surname>Barber</surname><given-names>C. A.</given-names></name><etal/></person-group><article-title>Detection of Zika virus using reverse-transcription LAMP coupled with reverse dot blot analysis in saliva</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2018</year><volume>13</volume><issue>2</issue><pub-id pub-id-type="publisher-id">e0192398</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0192398</pub-id><pub-id pub-id-type="other">2-s2.0-85041422788</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Rodriguez</surname><given-names>S. E.</given-names></name><name><surname>Elizondo-Quiroga</surname><given-names>D.</given-names></name><name><surname>Alvarez-Maya</surname><given-names>I.</given-names></name></person-group><article-title>Infectious diseases detection by microarray: an overview of clinical relevant infections</article-title><source><italic toggle="yes">Journal of Biomedical Science and Engineering</italic></source><year>2013</year><volume>6</volume><issue>10</issue><fpage>1006</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.4236/jbise.2013.610125</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>C. Y.</given-names></name><name><surname>Urisman</surname><given-names>A.</given-names></name><name><surname>Greenhow</surname><given-names>T. L.</given-names></name><etal/></person-group><article-title>Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children</article-title><source><italic toggle="yes">The Journal of Pediatrics</italic></source><year>2008</year><volume>153</volume><issue>1</issue><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2007.12.035</pub-id><pub-id pub-id-type="other">2-s2.0-47649120745</pub-id><pub-id pub-id-type="pmid">18571541</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Ditzen</surname><given-names>A.</given-names></name><name><surname>Hille</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Detection of herpesvirus and adenovirus co-infections with diagnostic DNA-microarrays</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2009</year><volume>155</volume><issue>2</issue><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2008.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-57749203795</pub-id><pub-id pub-id-type="pmid">19022297</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boriskin</surname><given-names>Y. S.</given-names></name><name><surname>Rice</surname><given-names>P. S.</given-names></name><name><surname>Stabler</surname><given-names>R. A.</given-names></name><etal/></person-group><article-title>DNA microarrays for virus detection in cases of central nervous system infection</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>12</issue><fpage>5811</fpage><lpage>5818</lpage><pub-id pub-id-type="doi">10.1128/jcm.42.12.5811-5818.2004</pub-id><pub-id pub-id-type="other">2-s2.0-10844247837</pub-id><pub-id pub-id-type="pmid">15583316</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>M. A.</given-names></name><name><surname>Soto-del R&#x000ed;o</surname><given-names>M. d. l. D.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>R. M.</given-names></name><etal/></person-group><article-title>DNA microarray for detection of gastrointestinal viruses</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2015</year><volume>53</volume><issue>1</issue><fpage>136</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1128/jcm.01317-14</pub-id><pub-id pub-id-type="other">2-s2.0-84919464055</pub-id><pub-id pub-id-type="pmid">25355758</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M. J.</given-names></name><name><surname>Trabuco</surname><given-names>A. C.</given-names></name><name><surname>Alfonso</surname><given-names>H. L.</given-names></name><etal/></person-group><article-title>DNA microarray platform for detection and surveillance of viruses transmitted by small mammals and arthropods</article-title><source><italic toggle="yes">PLoS Neglected Tropical Diseases</italic></source><year>2016</year><volume>10</volume><issue>9</issue><pub-id pub-id-type="publisher-id">e0005017</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005017</pub-id><pub-id pub-id-type="other">2-s2.0-84992051958</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korimbocus</surname><given-names>J.</given-names></name><name><surname>Scaramozzino</surname><given-names>N.</given-names></name><name><surname>Lacroix</surname><given-names>B.</given-names></name><name><surname>Crance</surname><given-names>J. M.</given-names></name><name><surname>Garin</surname><given-names>D.</given-names></name><name><surname>Vernet</surname><given-names>G.</given-names></name></person-group><article-title>DNA probe array for the simultaneous identification of herpesviruses, enteroviruses, and flaviviruses</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2005</year><volume>43</volume><issue>8</issue><fpage>3779</fpage><lpage>3787</lpage><pub-id pub-id-type="doi">10.1128/jcm.43.8.3779-3787.2005</pub-id><pub-id pub-id-type="other">2-s2.0-23744455067</pub-id><pub-id pub-id-type="pmid">16081910</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granade</surname><given-names>T. C.</given-names></name><name><surname>Kodani</surname><given-names>M.</given-names></name><name><surname>Wells</surname><given-names>S. K.</given-names></name><etal/></person-group><article-title>Characterization of real-time microarrays for simultaneous detection of HIV-1, HIV-2, and hepatitis viruses</article-title><source><italic toggle="yes">Journal of Virological Methods</italic></source><year>2018</year><volume>259</volume><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2018.06.001</pub-id><pub-id pub-id-type="other">2-s2.0-85048722768</pub-id><pub-id pub-id-type="pmid">29874550</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Badillo</surname><given-names>A.</given-names></name><name><surname>de Lourdes Mu&#x000f1;oz</surname><given-names>M.</given-names></name><name><surname>Perez-Ramirez</surname><given-names>G.</given-names></name><etal/></person-group><article-title>A DNA microarray-based assay to detect dual infection with two dengue virus serotypes</article-title><source><italic toggle="yes">Sensors</italic></source><year>2014</year><volume>14</volume><issue>5</issue><fpage>7580</fpage><lpage>7601</lpage><pub-id pub-id-type="doi">10.3390/s140507580</pub-id><pub-id pub-id-type="other">2-s2.0-84899640718</pub-id><pub-id pub-id-type="pmid">24776933</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n</surname><given-names>V.</given-names></name><name><surname>Perales</surname><given-names>C.</given-names></name><name><surname>Fern&#x000e0;ndez-Algar</surname><given-names>M.</given-names></name><etal/></person-group><article-title>An efficient microarray-based genotyping platform for the identification of drug-resistance mutations in majority and minority subpopulations of HIV-1 Quasispecies</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2016</year><volume>11</volume><issue>12</issue><pub-id pub-id-type="publisher-id">e0166902</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0166902</pub-id><pub-id pub-id-type="other">2-s2.0-85005978091</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masimba</surname><given-names>P.</given-names></name><name><surname>Gare</surname><given-names>J.</given-names></name><name><surname>Klimkait</surname><given-names>T.</given-names></name><name><surname>Tanner</surname><given-names>M.</given-names></name><name><surname>Felger</surname><given-names>I.</given-names></name></person-group><article-title>Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania</article-title><source><italic toggle="yes">Tropical Medicine and International Health</italic></source><year>2014</year><volume>19</volume><issue>6</issue><fpage>664</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1111/tmi.12289</pub-id><pub-id pub-id-type="other">2-s2.0-84899941800</pub-id><pub-id pub-id-type="pmid">24654946</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Xiang</surname><given-names>G.</given-names></name></person-group><article-title>Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection</article-title><source><italic toggle="yes">The Brazilian Journal of Infectious Diseases</italic></source><year>2015</year><volume>19</volume><issue>3</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.bjid.2015.03.012</pub-id><pub-id pub-id-type="other">2-s2.0-84930087989</pub-id><pub-id pub-id-type="pmid">25982306</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Geng</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name></person-group><article-title>Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus</article-title><source><italic toggle="yes">Journal of Microbiology and Biotechnology</italic></source><year>2014</year><volume>24</volume><issue>10</issue><fpage>1445</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.4014/jmb.1404.04024</pub-id><pub-id pub-id-type="other">2-s2.0-84924765083</pub-id><pub-id pub-id-type="pmid">24950883</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dankbar</surname><given-names>D. M.</given-names></name><name><surname>Dawson</surname><given-names>E. D.</given-names></name><name><surname>Mehlmann</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Diagnostic microarray for influenza B viruses</article-title><source><italic toggle="yes">Analytical Chemistry</italic></source><year>2007</year><volume>79</volume><issue>5</issue><fpage>2084</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1021/ac061960s</pub-id><pub-id pub-id-type="other">2-s2.0-33847648432</pub-id><pub-id pub-id-type="pmid">17326602</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Urisman</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Y. T.</given-names></name><etal/></person-group><article-title>Viral discovery and sequence recovery using DNA microarrays</article-title><source><italic toggle="yes">PLoS Biology</italic></source><year>2003</year><volume>1</volume><issue>2</issue><fpage>257</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0000002</pub-id><pub-id pub-id-type="other">2-s2.0-4243142644</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bexfield</surname><given-names>N.</given-names></name><name><surname>Kellam</surname><given-names>P.</given-names></name></person-group><article-title>Metagenomics and the molecular identification of novel viruses</article-title><source><italic toggle="yes">The Veterinary Journal</italic></source><year>2011</year><volume>190</volume><issue>2</issue><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2010.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-82855177787</pub-id><pub-id pub-id-type="pmid">21111643</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bumgarner</surname><given-names>R.</given-names></name></person-group><article-title>DNA microarrays: types, applications and their future</article-title><source><italic toggle="yes">Current Protocols in Molecular Biology</italic></source><year>2013</year><volume>22</volume><pub-id pub-id-type="doi">10.1002/0471142727.mb2201s101</pub-id><pub-id pub-id-type="other">2-s2.0-84877074259</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefterova</surname><given-names>M. I.</given-names></name><name><surname>Suarez</surname><given-names>C. J.</given-names></name><name><surname>Banaei</surname><given-names>N.</given-names></name><name><surname>Pinsky</surname><given-names>B. A.</given-names></name></person-group><article-title>Next-generation sequencing for infectious disease diagnosis and management</article-title><source><italic toggle="yes">The Journal of Molecular Diagnostics</italic></source><year>2015</year><volume>17</volume><issue>6</issue><fpage>623</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1016/j.jmoldx.2015.07.004</pub-id><pub-id pub-id-type="other">2-s2.0-84943656196</pub-id><pub-id pub-id-type="pmid">26433313</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vemula</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Biswas</surname><given-names>S.</given-names></name><name><surname>Hewlett</surname><given-names>I.</given-names></name></person-group><article-title>Current approaches for diagnosis of influenza virus infections in humans</article-title><source><italic toggle="yes">Viruses</italic></source><year>2016</year><volume>8</volume><issue>4</issue><fpage>p. 96</fpage><pub-id pub-id-type="doi">10.3390/v8040096</pub-id><pub-id pub-id-type="other">2-s2.0-84963783390</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deurenberg</surname><given-names>R. H.</given-names></name><name><surname>Bathoorn</surname><given-names>E.</given-names></name><name><surname>Chlebowicz</surname><given-names>M. A.</given-names></name><etal/></person-group><article-title>Application of next generation sequencing in clinical microbiology and infection prevention</article-title><source><italic toggle="yes">Journal of Biotechnology</italic></source><year>2017</year><volume>243</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2016.12.022</pub-id><pub-id pub-id-type="other">2-s2.0-85008312194</pub-id><pub-id pub-id-type="pmid">28042011</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laver</surname><given-names>T.</given-names></name><name><surname>Harrison</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>P. A.</given-names></name><etal/></person-group><article-title>Assessing the performance of the Oxford nanopore technologies MinION</article-title><source><italic toggle="yes">Biomolecular Detection and Quantification</italic></source><year>2015</year><volume>3</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.bdq.2015.02.001</pub-id><pub-id pub-id-type="other">2-s2.0-84925352769</pub-id><pub-id pub-id-type="pmid">26753127</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>M.</given-names></name><name><surname>Koren</surname><given-names>S.</given-names></name><name><surname>Miga</surname><given-names>K. H.</given-names></name><etal/></person-group><article-title>Nanopore sequencing and assembly of a human genome with ultra-long reads</article-title><source><italic toggle="yes">Nature Biotechnology</italic></source><year>2018</year><volume>36</volume><issue>4</issue><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/nbt.4060</pub-id><pub-id pub-id-type="other">2-s2.0-85044543338</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>W.</given-names></name><name><surname>Hua</surname><given-names>K. Y.</given-names></name><name><surname>Yong</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Rapid and accurate sequencing of enterovirus genomes using MinION nanopore sequencer</article-title><source><italic toggle="yes">Biomedical and Environmental Sciences</italic></source><year>2017</year><volume>30</volume><issue>10</issue><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.3967/bes2017.097</pub-id><pub-id pub-id-type="other">2-s2.0-85034017538</pub-id><pub-id pub-id-type="pmid">29122092</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>K.</given-names></name><name><surname>Tamura</surname><given-names>K.</given-names></name><name><surname>Tanigaki</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Whole genome sequencing of influenza A and B viruses with the MinION sequencer in the clinical setting: a pilot study</article-title><source><italic toggle="yes">Frontiers in Microbiology</italic></source><year>2018</year><volume>9</volume><fpage>p. 2748</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.02748</pub-id><pub-id pub-id-type="other">2-s2.0-85056819170</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quick</surname><given-names>J.</given-names></name><name><surname>Grubaugh</surname><given-names>N. D.</given-names></name><name><surname>Pullan</surname><given-names>S. T.</given-names></name><etal/></person-group><article-title>Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples</article-title><source><italic toggle="yes">Nature Protocols</italic></source><year>2017</year><volume>12</volume><issue>6</issue><fpage>1261</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1038/nprot.2017.066</pub-id><pub-id pub-id-type="other">2-s2.0-85019741923</pub-id><pub-id pub-id-type="pmid">28538739</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kustin</surname><given-names>T.</given-names></name><name><surname>Ling</surname><given-names>G.</given-names></name><name><surname>Sharabi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A method to identify respiratory virus infections in clinical samples using next-generation sequencing</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2019</year><volume>9</volume><fpage>p. 2606</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-37483-w</pub-id><pub-id pub-id-type="other">2-s2.0-85062011896</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baillie</surname><given-names>G. J.</given-names></name><name><surname>Galiano</surname><given-names>M.</given-names></name><name><surname>Agapow</surname><given-names>P.-M.</given-names></name><etal/></person-group><article-title>Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2012</year><volume>86</volume><issue>1</issue><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1128/jvi.05347-11</pub-id><pub-id pub-id-type="other">2-s2.0-84855927073</pub-id><pub-id pub-id-type="pmid">22013031</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessilly</surname><given-names>G.</given-names></name><name><surname>Goeminne</surname><given-names>L.</given-names></name><name><surname>Vandenbroucke</surname><given-names>A.-t</given-names></name><name><surname>Dufrasne</surname><given-names>F. E.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Kabamba-Mukabi</surname><given-names>B.</given-names></name></person-group><article-title>First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2018</year><volume>13</volume><issue>12</issue><pub-id pub-id-type="publisher-id">e0209561</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0209561</pub-id><pub-id pub-id-type="other">2-s2.0-85059269574</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Towner</surname><given-names>J. S.</given-names></name><name><surname>Sealy</surname><given-names>T. K.</given-names></name><name><surname>Khristova</surname><given-names>M. L.</given-names></name><etal/></person-group><article-title>Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2008</year><volume>4</volume><issue>11</issue><pub-id pub-id-type="publisher-id">e1000212</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000212</pub-id><pub-id pub-id-type="other">2-s2.0-57149120780</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Farooqui</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Next-generation sequencing and bioinformatic approaches to detect and analyze influenza virus in ferrets</article-title><source><italic toggle="yes">The Journal of Infection in Developing Countries</italic></source><year>2014</year><volume>8</volume><issue>4</issue><fpage>498</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.3855/jidc.3749</pub-id><pub-id pub-id-type="other">2-s2.0-84898463443</pub-id><pub-id pub-id-type="pmid">24727517</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jerome</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>C.</given-names></name><name><surname>Sreenu</surname><given-names>V. B.</given-names></name><etal/></person-group><article-title>Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers</article-title><source><italic toggle="yes">Journal of Infection</italic></source><year>2019</year><volume>79</volume><issue>4</issue><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2019.08.003</pub-id><pub-id pub-id-type="other">2-s2.0-85071361153</pub-id><pub-id pub-id-type="pmid">31398374</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kindt</surname><given-names>T. J.</given-names></name><name><surname>Goldsby</surname><given-names>R. A.</given-names></name><name><surname>Osborne</surname><given-names>B. A.</given-names></name></person-group><source><italic toggle="yes">Kuby Immunology</italic></source><year>2007</year><edition>6th</edition><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>W.H. Freeman and Company</publisher-name><fpage>155</fpage><lpage>161</lpage></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>D.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name></person-group><article-title>Nucleoprotein-based indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marbug virus</article-title><source><italic toggle="yes">Virologica Sinica</italic></source><year>2014</year><volume>29</volume><issue>6</issue><fpage>372</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1007/s12250-014-3512-0</pub-id><pub-id pub-id-type="other">2-s2.0-84920093272</pub-id><pub-id pub-id-type="pmid">25547682</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>E. R.</given-names></name><name><surname>Ainsworth</surname><given-names>M.</given-names></name><name><surname>Anand</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Evaluation of antibody testing for SARS-CoV-2 using ELISA and lateral flow immunoassays</article-title><source><italic toggle="yes">MedRxiv</italic></source><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/medrxiv/early/2020/07/07/2020.04.15.20066407">https://www.medrxiv.org/content/medrxiv/early/2020/07/07/2020.04.15.20066407</ext-link></comment><pub-id pub-id-type="doi">10.1101/2020.04.15.20066407</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colavita</surname><given-names>F.</given-names></name><name><surname>Brogi</surname><given-names>A.</given-names></name><name><surname>Lapa</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Evaluation of ELISA tests for the qualitative determination of IgG, IgM and IgA to SARS-CoV-2</article-title><source><italic toggle="yes">MedRxiv</italic></source><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/cgi/content/short/2020.05.24.20111682">http://medrxiv.org/cgi/content/short/2020.05.24.20111682</ext-link></comment><pub-id pub-id-type="doi">10.1101/2020.05.24.20111682</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>S.-C.</given-names></name><name><surname>Huang</surname><given-names>Y.-Y.</given-names></name><name><surname>Shu</surname><given-names>P.-Y.</given-names></name><etal/></person-group><article-title>Development of an enzyme-linked immunosorbent assay for rapid detection of dengue virus (DENV) NS1 and differentiation of DENV serotypes during early infection</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2019</year><volume>57</volume><issue>7</issue><fpage>19</fpage><pub-id pub-id-type="publisher-id">e00221-19</pub-id><pub-id pub-id-type="doi">10.1128/jcm.00221-19</pub-id><pub-id pub-id-type="other">2-s2.0-85068522919</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kebede</surname><given-names>Y.</given-names></name><name><surname>Dorigo-Zetsma</surname><given-names>W.</given-names></name><name><surname>Mengistu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Transmission of Herpes simplex virus type 2 among factory workers in Ethiopia</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2004</year><volume>190</volume><issue>2</issue><fpage>365</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1086/422038</pub-id><pub-id pub-id-type="other">2-s2.0-3242719277</pub-id><pub-id pub-id-type="pmid">15216474</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>S. K. P.</given-names></name><name><surname>Woo</surname><given-names>P. C. Y.</given-names></name><name><surname>Wong</surname><given-names>B. H. L.</given-names></name><etal/></person-group><article-title>Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>7</issue><fpage>2884</fpage><lpage>2889</lpage><pub-id pub-id-type="doi">10.1128/jcm.42.7.2884-2889.2004</pub-id><pub-id pub-id-type="other">2-s2.0-3142679423</pub-id><pub-id pub-id-type="pmid">15243033</pub-id></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amado</surname><given-names>L. A.</given-names></name><name><surname>Villar</surname><given-names>L. M.</given-names></name><name><surname>de Paula</surname><given-names>V. S.</given-names></name><name><surname>Almeida</surname><given-names>A. J. d.</given-names></name><name><surname>Gaspar</surname><given-names>A. M. C.</given-names></name></person-group><article-title>Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies</article-title><source><italic toggle="yes">Mem&#x000f3;rias Do Instituto Oswaldo Cruz</italic></source><year>2006</year><volume>101</volume><issue>2</issue><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1590/s0074-02762006000200006</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Kono</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus</article-title><source><italic toggle="yes">Japanese Journal of Infectious Diseases</italic></source><year>2012</year><volume>65</volume><issue>1</issue><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">22274153</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huzly</surname><given-names>D.</given-names></name><name><surname>Hanselmann</surname><given-names>I.</given-names></name><name><surname>Schmidt-Chanasit</surname><given-names>J.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name></person-group><article-title>High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses</article-title><source><italic toggle="yes">Eurosurveillance</italic></source><year>2016</year><volume>21</volume><fpage>p. 30203</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.es.2016.21.16.30203</pub-id><pub-id pub-id-type="other">2-s2.0-85015353018</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt&#x000f2;</surname><given-names>S.</given-names></name><name><surname>Suligoi</surname><given-names>B.</given-names></name><name><surname>Fanales-Belasio</surname><given-names>E.</given-names></name><name><surname>Raimondo</surname><given-names>M.</given-names></name></person-group><article-title>Laboratory diagnostics for HIV infection</article-title><source><italic toggle="yes">Annali dell&#x02019;Istituto Superiore di Sanit&#x000e0;</italic></source><year>2010</year><volume>46</volume><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1590/s0021-25712010000100004</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Chong</surname><given-names>K. H.</given-names></name><name><surname>Chng</surname><given-names>H. H.</given-names></name><etal/></person-group><article-title>Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome</article-title><source><italic toggle="yes">Clinical Diagnostic Laboratory Immunology</italic></source><year>2004</year><volume>11</volume><issue>2</issue><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1128/cdli.11.2.417-422.2004</pub-id><pub-id pub-id-type="other">2-s2.0-1642268167</pub-id><pub-id pub-id-type="pmid">15013997</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Ahn</surname><given-names>H.-J.</given-names></name><name><surname>Chong</surname><given-names>C.-K.</given-names></name><name><surname>Dias</surname><given-names>R. F.</given-names></name><name><surname>Nam</surname><given-names>H.-W.</given-names></name></person-group><article-title>Western blot detection of human anti-Chikungunya virus antibody with recombinant envelope 2 protein</article-title><source><italic toggle="yes">The Korean Journal of Parasitology</italic></source><year>2016</year><volume>54</volume><issue>2</issue><fpage>239</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.3347/kjp.2016.54.2.239</pub-id><pub-id pub-id-type="other">2-s2.0-84964988357</pub-id><pub-id pub-id-type="pmid">27180586</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Western blot-based logistic regression model for the identification of recent HIV-1 infection: a promising HIV-1 surveillance approach for resource-limited regions</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2018</year><volume>2018</volume><fpage>8</fpage><pub-id pub-id-type="publisher-id">4390318</pub-id><pub-id pub-id-type="doi">10.1155/2018/4390318</pub-id><pub-id pub-id-type="other">2-s2.0-85045901396</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>C. T.</given-names></name><name><surname>Han</surname><given-names>C. M.</given-names></name><name><surname>Lo</surname><given-names>S. Y.</given-names></name><etal/></person-group><article-title>Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>1994</year><volume>32</volume><issue>9</issue><fpage>2235</fpage><lpage>2241</lpage><pub-id pub-id-type="doi">10.1128/jcm.32.9.2235-2241.1994</pub-id><pub-id pub-id-type="pmid">7529251</pub-id></element-citation></ref><ref id="B147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>J. B.</given-names></name><name><surname>Parsons</surname><given-names>J. S.</given-names></name><name><surname>Nichols</surname><given-names>L. S.</given-names></name><name><surname>Knoble</surname><given-names>N.</given-names></name><name><surname>Kennedy</surname><given-names>S.</given-names></name><name><surname>Piwowar</surname><given-names>E. M.</given-names></name></person-group><article-title>Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>1997</year><volume>35</volume><issue>5</issue><fpage>1118</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1128/jcm.35.5.1118-1121.1997</pub-id><pub-id pub-id-type="pmid">9114392</pub-id></element-citation></ref><ref id="B148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudha</surname><given-names>T.</given-names></name><name><surname>Lakshmi</surname><given-names>V.</given-names></name><name><surname>Teja</surname><given-names>V. D.</given-names></name></person-group><article-title>Western blot profile in HIV infection</article-title><source><italic toggle="yes">Indian Journal of Dermatology, Venereology and Leprology</italic></source><year>2006</year><volume>72</volume><issue>5</issue><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.4103/0378-6323.27752</pub-id></element-citation></ref><ref id="B149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitsch-Osuch</surname><given-names>A.</given-names></name><name><surname>Wo&#x0017a;niak-Kosek</surname><given-names>A.</given-names></name><name><surname>Brydak</surname><given-names>L.</given-names></name></person-group><article-title>Accuracy of rapid influenza diagnostic test and immunofluorescence assay compared to real time RT-PCR in children with influenza A(H1N1)pdm09 infection</article-title><source><italic toggle="yes">Post&#x00119;py Higieny I Medycyny Do&#x0015b;wiadczalnej</italic></source><year>2012</year><volume>66</volume><fpage>752</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.5604/17322693.1015040</pub-id><pub-id pub-id-type="other">2-s2.0-84867964311</pub-id><pub-id pub-id-type="pmid">23175329</pub-id></element-citation></ref><ref id="B150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>P. K. S.</given-names></name><name><surname>Ng</surname><given-names>K.-C.</given-names></name><name><surname>Chan</surname><given-names>R. C. W.</given-names></name><etal/></person-group><article-title>Immunofluorescence assay for serologic diagnosis of SARS</article-title><source><italic toggle="yes">Emerging Infectious Diseases</italic></source><year>2004</year><volume>10</volume><issue>3</issue><fpage>530</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.3201/eid1003.030493</pub-id><pub-id pub-id-type="other">2-s2.0-12144287294</pub-id><pub-id pub-id-type="pmid">15109430</pub-id></element-citation></ref><ref id="B151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouletty</surname><given-names>P.</given-names></name><name><surname>Chomel</surname><given-names>J. J.</given-names></name><name><surname>Thouvenot</surname><given-names>D.</given-names></name><name><surname>Catalan</surname><given-names>F.</given-names></name><name><surname>Rabillon</surname><given-names>V.</given-names></name><name><surname>Kadouche</surname><given-names>J.</given-names></name></person-group><article-title>Detection of herpes simplex virus in direct specimens by immunofluorescence assay using a monoclonal antibody</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>1987</year><volume>25</volume><issue>5</issue><fpage>958</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1128/jcm.25.5.958-959.1987</pub-id><pub-id pub-id-type="pmid">3034970</pub-id></element-citation></ref><ref id="B152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhusudana</surname><given-names>S. N.</given-names></name><name><surname>Shamsundar</surname><given-names>R.</given-names></name><name><surname>Saraswati</surname><given-names>S.</given-names></name></person-group><article-title>Comparative evaluation of a simple indirect immunofluorescence test and mouse neutralization test for assaying rabies antibodies</article-title><source><italic toggle="yes">Indian Journal of Pathology and Microbiology</italic></source><year>2001</year><volume>44</volume><issue>3</issue><fpage>309</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">12024919</pub-id></element-citation></ref><ref id="B153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Higgins</surname><given-names>A.</given-names></name><name><surname>Navarro</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Subtyping influenza A virus with monoclonal antibodies and an indirect immunofluorescence assay</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2012</year><volume>50</volume><issue>2</issue><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1128/jcm.01237-11</pub-id><pub-id pub-id-type="other">2-s2.0-84862939615</pub-id><pub-id pub-id-type="pmid">22075584</pub-id></element-citation></ref><ref id="B154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiptoo</surname><given-names>M. K.</given-names></name><name><surname>Mpoke</surname><given-names>S. S.</given-names></name><name><surname>Ng&#x02019;ang&#x02019;a</surname><given-names>Z. W.</given-names></name></person-group><article-title>New indirect immunofluorescence assay as a confirmatory test for human immunodeficiency virus type 1</article-title><source><italic toggle="yes">East African Medical Journal</italic></source><year>2004</year><volume>81</volume><issue>5</issue><fpage>222</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.4314/eamj.v81i5.9163</pub-id><pub-id pub-id-type="other">2-s2.0-16544381450</pub-id><pub-id pub-id-type="pmid">15508334</pub-id></element-citation></ref><ref id="B155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafik</surname><given-names>C. F.</given-names></name><name><surname>Mohareb</surname><given-names>E. W.</given-names></name><name><surname>Youssef</surname><given-names>F. G.</given-names></name></person-group><article-title>Comparison of direct fluorescence assay and real-time RT-PCR as diagnostics for respiratory syncytial virus in young children</article-title><source><italic toggle="yes">Journal of Tropical Medicine</italic></source><year>2011</year><volume>2011</volume><fpage>3</fpage><pub-id pub-id-type="publisher-id">781919</pub-id><pub-id pub-id-type="doi">10.1155/2011/781919</pub-id><pub-id pub-id-type="other">2-s2.0-84855611827</pub-id></element-citation></ref><ref id="B156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ory</surname><given-names>F.</given-names></name><name><surname>S&#x000e1;nchez-Seco</surname><given-names>M.</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Comparative evaluation of indirect immunofluorescence and NS-1-based ELISA to determine Zika virus-specific IgM</article-title><source><italic toggle="yes">Viruses</italic></source><year>2018</year><volume>10</volume><issue>7</issue><fpage>p. 379</fpage><pub-id pub-id-type="doi">10.3390/v10070379</pub-id><pub-id pub-id-type="other">2-s2.0-85050622114</pub-id></element-citation></ref><ref id="B157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mather</surname><given-names>S.</given-names></name><name><surname>Scott</surname><given-names>S.</given-names></name><name><surname>Temperton</surname><given-names>N.</given-names></name><name><surname>Wright</surname><given-names>E.</given-names></name><name><surname>King</surname><given-names>B.</given-names></name><name><surname>Daly</surname><given-names>J.</given-names></name></person-group><article-title>Current progress with serological assays for exotic emerging/re-emerging viruses</article-title><source><italic toggle="yes">Future Virology</italic></source><year>2013</year><volume>8</volume><issue>8</issue><fpage>745</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.2217/fvl.13.60</pub-id><pub-id pub-id-type="other">2-s2.0-84881420294</pub-id></element-citation></ref><ref id="B158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alladi</surname><given-names>C. S. H.</given-names></name><name><surname>Jagadesh</surname><given-names>A.</given-names></name><name><surname>Prabhu</surname><given-names>S. G.</given-names></name><name><surname>Arunkumar</surname><given-names>G.</given-names></name></person-group><article-title>Hemagglutination inhibition antibody response following influenza A(H1N1)pdm09 virus natural infection: a cross-sectional study from thirthahalli, Karnataka, India</article-title><source><italic toggle="yes">Viral Immunology</italic></source><year>2019</year><volume>32</volume><issue>5</issue><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1089/vim.2019.0010</pub-id><pub-id pub-id-type="other">2-s2.0-85066990039</pub-id><pub-id pub-id-type="pmid">31070522</pub-id></element-citation></ref><ref id="B159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Numazaki</surname><given-names>K.</given-names></name></person-group><article-title>Study on assays for the detection of serum antibodies to measles from children and its standardization</article-title><source><italic toggle="yes">International Journal of Pediatrics and Neonatal Care</italic></source><year>2015</year><volume>1</volume><fpage>p. 108</fpage><pub-id pub-id-type="doi">10.15344/2455-2364/2015/108</pub-id></element-citation></ref><ref id="B160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noah</surname><given-names>D. L.</given-names></name><name><surname>Hill</surname><given-names>H.</given-names></name><name><surname>Hines</surname><given-names>D.</given-names></name><name><surname>White</surname><given-names>E. L.</given-names></name><name><surname>Wolff</surname><given-names>M. C.</given-names></name></person-group><article-title>Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure</article-title><source><italic toggle="yes">Clinical and Vaccine Immunology</italic></source><year>2009</year><volume>16</volume><issue>4</issue><fpage>558</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1128/cvi.00368-08</pub-id><pub-id pub-id-type="other">2-s2.0-64549129973</pub-id><pub-id pub-id-type="pmid">19225073</pub-id></element-citation></ref><ref id="B161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veguilla</surname><given-names>V.</given-names></name><name><surname>Hancock</surname><given-names>K.</given-names></name><name><surname>Schiffer</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2011</year><volume>49</volume><issue>6</issue><fpage>2210</fpage><lpage>2215</lpage><pub-id pub-id-type="doi">10.1128/jcm.00229-11</pub-id><pub-id pub-id-type="other">2-s2.0-79957451495</pub-id><pub-id pub-id-type="pmid">21471339</pub-id></element-citation></ref><ref id="B162"><label>162</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schiettecatte</surname><given-names>J.</given-names></name><name><surname>Anckaert</surname><given-names>E.</given-names></name><name><surname>Smitz</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Chiu</surname><given-names>N. H. L.</given-names></name><name><surname>Christopoulos</surname><given-names>T. K.</given-names></name></person-group><article-title>Interferences in immunoassays</article-title><source><italic toggle="yes">Advances in Immunoassay Technology</italic></source><year>2012</year><publisher-loc>Rijeka, Croatia</publisher-loc><publisher-name>InTech</publisher-name><fpage>45</fpage><lpage>55</lpage></element-citation></ref><ref id="B163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerson</surname><given-names>J. F.</given-names></name><name><surname>Lai</surname><given-names>K. K. Y.</given-names></name></person-group><article-title>Endogenous antibody interferences in immunoassays</article-title><source><italic toggle="yes">Laboratory Medicine</italic></source><year>2013</year><volume>44</volume><issue>1</issue><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1309/lmmurcfqhksb5yec</pub-id></element-citation></ref><ref id="B164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholzen</surname><given-names>A.</given-names></name><name><surname>Sauerwein</surname><given-names>R. W.</given-names></name></person-group><article-title>How malaria modulates memory: activation and dysregulation of B cells in <italic>Plasmodium</italic> infection</article-title><source><italic toggle="yes">Trends in Parasitology</italic></source><year>2013</year><volume>29</volume><issue>5</issue><fpage>252</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2013.03.002</pub-id><pub-id pub-id-type="other">2-s2.0-84876854461</pub-id><pub-id pub-id-type="pmid">23562778</pub-id></element-citation></ref><ref id="B165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Esbroeck</surname><given-names>M.</given-names></name><name><surname>Meersman</surname><given-names>K.</given-names></name><name><surname>Michiels</surname><given-names>J.</given-names></name><name><surname>Ari&#x000eb;n</surname><given-names>K. K.</given-names></name><name><surname>Van den Bossche</surname><given-names>D.</given-names></name></person-group><article-title>Letter to the editor: specificity of Zika virus ELISA: interference with malaria</article-title><source><italic toggle="yes">Eurosurveillance</italic></source><year>2016</year><volume>21</volume><issue>21</issue><pub-id pub-id-type="publisher-id">30237</pub-id><pub-id pub-id-type="doi">10.2807/1560-7917.es.2016.21.21.30237</pub-id><pub-id pub-id-type="other">2-s2.0-85015355126</pub-id></element-citation></ref><ref id="B166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>C.</given-names></name><name><surname>Ammayappan</surname><given-names>A.</given-names></name><name><surname>Vakharia</surname><given-names>V. N.</given-names></name></person-group><article-title>Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens</article-title><source><italic toggle="yes">Virology Journal</italic></source><year>2009</year><volume>6</volume><issue>1</issue><fpage>p. 158</fpage><pub-id pub-id-type="doi">10.1186/1743-422x-6-158</pub-id><pub-id pub-id-type="other">2-s2.0-70350335336</pub-id><pub-id pub-id-type="pmid">19811655</pub-id></element-citation></ref><ref id="B167"><label>167</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ogilvie</surname><given-names>M. M.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Burnett</surname><given-names>D.</given-names></name><name><surname>Crocker</surname><given-names>J.</given-names></name></person-group><article-title>Microscopy in virology: application and sample preparation</article-title><source><italic toggle="yes">The Science of Laboratory Diagnosis</italic></source><year>2005</year><edition>2nd</edition><publisher-loc>West Sussex, UK</publisher-loc><publisher-name>John Wiley &#x00026; Sons</publisher-name><fpage>175</fpage><lpage>177</lpage></element-citation></ref><ref id="B168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aseffa</surname><given-names>A.</given-names></name></person-group><article-title>Viral diseases in Ethiopia: a review</article-title><source><italic toggle="yes">East African Medical Journal</italic></source><year>1993</year><volume>70</volume><issue>10</issue><fpage>624</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">8187657</pub-id></element-citation></ref><ref id="B169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abebe</surname><given-names>A.</given-names></name><name><surname>Nokes</surname><given-names>D. J.</given-names></name><name><surname>Dejene</surname><given-names>A.</given-names></name><name><surname>Enquselassie</surname><given-names>F.</given-names></name><name><surname>Messele</surname><given-names>T.</given-names></name><name><surname>Cutts</surname><given-names>F. T.</given-names></name></person-group><article-title>Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control</article-title><source><italic toggle="yes">Epidemiology and Infection</italic></source><year>2003</year><volume>131</volume><issue>1</issue><fpage>757</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1017/s0950268803008574</pub-id><pub-id pub-id-type="other">2-s2.0-0042856319</pub-id><pub-id pub-id-type="pmid">12948377</pub-id></element-citation></ref><ref id="B170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayele</surname><given-names>A. G.</given-names></name><name><surname>Gebre-Selassie</surname><given-names>S.</given-names></name></person-group><article-title>Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa, Ethiopia</article-title><source><italic toggle="yes">ISRN Tropical Medicine</italic></source><year>2013</year><volume>2013</volume><fpage>7</fpage><pub-id pub-id-type="publisher-id">563821</pub-id><pub-id pub-id-type="doi">10.1155/2013/563821</pub-id></element-citation></ref><ref id="B171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>C. R.</given-names></name><name><surname>Tsoumanis</surname><given-names>A.</given-names></name><name><surname>Schwartz</surname><given-names>I. S.</given-names></name></person-group><article-title>HIV prevalence correlates with high-risk sexual behavior in Ethiopia&#x02019;s regions</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2015</year><volume>10</volume><issue>10</issue><pub-id pub-id-type="publisher-id">e0140835</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0140835</pub-id><pub-id pub-id-type="other">2-s2.0-84949461193</pub-id></element-citation></ref><ref id="B172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deressa</surname><given-names>A.</given-names></name><name><surname>Pal</surname><given-names>M.</given-names></name><name><surname>Mamo</surname><given-names>H.</given-names></name><name><surname>Haile</surname><given-names>A.</given-names></name><name><surname>Dasgupta</surname><given-names>R.</given-names></name></person-group><article-title>Rabies: a major fatal viral disease of humans and animals in Ethiopia</article-title><source><italic toggle="yes">Journal of Natural History</italic></source><year>2015</year><volume>11</volume><issue>2</issue><fpage>19</fpage><lpage>26</lpage></element-citation></ref><ref id="B173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayele</surname><given-names>W.</given-names></name><name><surname>Demissie</surname><given-names>G.</given-names></name><name><surname>Kassa</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Challenges of establishing routine influenza sentinel surveillance in Ethiopia, 2008-2010</article-title><source><italic toggle="yes">Journal of Infectious Diseases</italic></source><year>2012</year><volume>206</volume><issue>1</issue><fpage>S41</fpage><lpage>S45</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis531</pub-id><pub-id pub-id-type="other">2-s2.0-84870033128</pub-id><pub-id pub-id-type="pmid">23169970</pub-id></element-citation></ref><ref id="B174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>J. M.</given-names></name><name><surname>Alegria</surname><given-names>I.</given-names></name><name><surname>Tessema</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Epidemiology of Rotavirus diarrhea among children aged less than 5 years in rural southern Ethiopia</article-title><source><italic toggle="yes">The Southeast Asian Journal of Tropical Medicine and Public Health</italic></source><year>2015</year><volume>46</volume><issue>3</issue><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">26521516</pub-id></element-citation></ref><ref id="B175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belete</surname><given-names>W.</given-names></name><name><surname>Deressa</surname><given-names>T.</given-names></name><name><surname>Feleke</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Evaluation of diagnostic performance of non-invasive HIV self-testing kit using oral fluid in Addis Ababa, Ethiopia: a facility-based cross-sectional study</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2019</year><volume>14</volume><issue>1</issue><pub-id pub-id-type="publisher-id">e0210866</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0210866</pub-id><pub-id pub-id-type="other">2-s2.0-85060528186</pub-id></element-citation></ref><ref id="B176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Mengistu</surname><given-names>F.</given-names></name><name><surname>Hussen</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Overview of rabies in and around Addis Ababa, in animals examined in EHNRI zoonoses laboratory between, 2003 and 2009</article-title><source><italic toggle="yes">Ethiopian Veterinary Journal</italic></source><year>2010</year><volume>14</volume><issue>2</issue><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.4314/evj.v14i2.63927</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic of the use of TaqMan probe in real-time PCR.</p></caption><graphic xlink:href="ijmicro2020-8832728.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Diagram of molecular beacon. (A) The molecule forms hairpin when free in solution. This brings fluorophore (yellow ball) and quencher (black ball) in close proximity, so that no fluorescent light is detected. (B) The molecule hybridizes to the target sequence. This separates the fluorophore and quencher and leads to emission of fluorescent light.</p></caption><graphic xlink:href="ijmicro2020-8832728.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Schematic of the principle of NASBA. Abbreviations: P1, primer 1; P2, primer 2; RT, reverse transcriptase.</p></caption><graphic xlink:href="ijmicro2020-8832728.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Diagram of the two principles of ELISA. (A) Sandwich ELISA. (B) Indirect ELISA. Abbreviations: E, enzyme; S, substrate; P, product.</p></caption><graphic xlink:href="ijmicro2020-8832728.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Schematic of immunoblot analysis of viral protein. Abbreviations: M.W., molecular weight; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; NCM, nitrocellulose membrane.</p></caption><graphic xlink:href="ijmicro2020-8832728.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Schematic of the principles of immunofluorescence assays: (A) direct immunofluorescence assay; (B) indirect immunofluorescence assay.</p></caption><graphic xlink:href="ijmicro2020-8832728.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Hemagglutination inhibition assay of avian influenza virus. When the RBCs are alone, they will settle in the bottom of the well. Where specific antibody is absent in the clinical specimen, the viral hemagglutinin is free to agglutinate the RBCs. The HI titer of S1&#x02013;S5 is 2<sup>10</sup>. Abbreviations: R, RBCs only; V&#x02009;+&#x02009;R, virus and RBCs; PC, positive control; S, sample (unpublished data).</p></caption><graphic xlink:href="ijmicro2020-8832728.007"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Advantages and limitations of nucleic acid-based amplification techniques.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Detection methods</th><th align="left" rowspan="1" colspan="1">Advantages</th><th align="left" rowspan="1" colspan="1">Limitations</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">Conventional PCR</td><td align="left" rowspan="1" colspan="1">(i) Sensitive and specific</td><td align="left" rowspan="1" colspan="1">(i) High risk of contamination</td><td rowspan="5" align="center" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">(ii) Widely employed nucleic acid-based detection format</td><td align="left" rowspan="1" colspan="1">(ii) Prone to inhibitors</td></tr><tr><td align="left" rowspan="1" colspan="1">(iii) Multiplex detection potential</td><td align="left" rowspan="1" colspan="1">(iii) Time-consuming and labor-intensive</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(iv) Qualitative</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(v) Requires thermal cycler and gel documentation apparatus</td></tr><tr><td align="left" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="6" colspan="1">Conventional RT-PCR</td><td align="left" rowspan="1" colspan="1">(i) Sensitive and specific</td><td align="left" rowspan="1" colspan="1">(i) RNA handling might be difficult</td><td rowspan="6" align="center" colspan="1">[<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B36" ref-type="bibr">36</xref>&#x02013;<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">(ii) Multiplex detection potential</td><td align="left" rowspan="1" colspan="1">(ii) High risk of contamination</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(iii) Time-consuming and cumbersome</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(iv) Relatively expensive</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(v) Prone to inhibitors</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">(vi) Mutation within PCR primer regions may occur in some RNA viruses which have high mutation rates, leading to reduced sensitivity</td></tr><tr><td align="left" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="6" colspan="1">Real-time PCR/RT-qPCR</td><td align="left" rowspan="1" colspan="1">(i) Highly sensitive and specific</td><td align="left" rowspan="1" colspan="1">(i) Requires expensive laboratory equipment and fluorescent probe</td><td rowspan="6" align="center" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B39" ref-type="bibr">39</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">(ii) Lower cross-contamination risk due to closed tube operation</td><td align="left" rowspan="1" colspan="1">(ii) Designing of TaqMan probes requires almost complete information of the target nucleic acid sequence</td></tr><tr><td align="left" rowspan="1" colspan="1">(iii) Rapid and less labor-intensive</td><td align="left" rowspan="1" colspan="1">(iii) Primer dimer artifact is a problem in case of SYBR green method</td></tr><tr><td align="left" rowspan="1" colspan="1">(iv) Multiplex detection</td><td align="left" rowspan="1" colspan="1">(iv) Prone to inhibitors</td></tr><tr><td align="left" rowspan="1" colspan="1">(v) Genotyping</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(vi) Determination of the viral load (quantitative)</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="6" colspan="1">TMA&#x02009;+&#x02009;NASBA</td><td align="left" rowspan="1" colspan="1">(i) Sensitive and specific</td><td align="left" rowspan="1" colspan="1">(i) RNA handling might be difficult</td><td rowspan="6" align="center" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B42" ref-type="bibr">42</xref>&#x02013;<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">(ii) Simple and rapid (fewer cycles are required)</td><td align="left" rowspan="1" colspan="1">(ii) Requirement of three enzymes in case of NASBA</td></tr><tr><td align="left" rowspan="1" colspan="1">(iii) Multiplexing potential</td><td align="left" rowspan="1" colspan="1">(iii) Use of enzymes that are not thermostable</td></tr><tr><td align="left" rowspan="1" colspan="1">(iv) Quantification,</td><td align="left" rowspan="1" colspan="1">(iv) Nonspecific interactions of the primers may increase as the amplification process occurs at a lower temperature (41&#x000b0;C)</td></tr><tr><td align="left" rowspan="1" colspan="1">(v) Genotyping</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(vi) Does not require thermal cycler as the reaction takes place isothermally at 41&#x000b0;C</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="8" colspan="1">LAMP/LAMP-RT</td><td align="left" rowspan="1" colspan="1">(i) Highly sensitive and specific</td><td align="left" rowspan="1" colspan="1">(i) Requirement of six primers</td><td rowspan="8" align="center" colspan="1">[<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B46" ref-type="bibr">46</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">(ii) Easy to perform</td><td align="left" rowspan="1" colspan="1">(ii) High risk of carryover contamination</td></tr><tr><td align="left" rowspan="1" colspan="1">(iii) Does not require expensive thermal cycler</td><td align="left" rowspan="1" colspan="1">(iii) Limitation for multiplexing</td></tr><tr><td align="left" rowspan="1" colspan="1">(iv) Rapid (results in &#x0003c;1&#x02009;h)</td><td align="left" rowspan="1" colspan="1">(iv) Visual detection using naked eye alone is subjective since it depends on observer's perception of color</td></tr><tr><td align="left" rowspan="1" colspan="1">(v) Quantitative</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(vi) Genotyping</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(vii) Simple detection systems (using naked eye)</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(viii) Relatively resistant to inhibitors present in the sample</td><td align="left" rowspan="1" colspan="1">&#x02009;</td></tr></tbody></table></table-wrap></floats-group></article>